| C552530 | 1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane | "1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane inhibits the reaction [EP300 protein binds to BIRC5 promoter]" | 20660371 |
| C552530 | 1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane | "1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in decreased expression of BIRC5 mRNA" | 20660371 |
| C552530 | 1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane | "1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in decreased expression of BIRC5 protein" | 20660371|2603571 |
| C552530 | 1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane | "NR4A1 protein inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in decreased expression of BIRC5 mRNA]" | 20660371 |
| C552530 | 1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane | "NR4A1 protein inhibits the reaction [1,1-bis(3'-indolyl)-1-(4-hydroxyphenyl)methane results in increased expression of BIRC5 protein]" | 20660371 |
| C504897 | 12-(3-adamantan-1-ylureido)dodecanoic acid | 12-(3-adamantan-1-ylureido)dodecanoic acid results in decreased expression of BIRC5 mRNA | 19435785 |
| C026486 | 1,2,5,6-dibenzanthracene | "1,2,5,6-dibenzanthracene results in increased expression of BIRC5 mRNA" | 26377693 |
| C028474 | 1,4-bis(2-(3,5-dichloropyridyloxy))benzene | "1,4-bis(2-(3,5-dichloropyridyloxy))benzene results in increased expression of BIRC5 mRNA" | 21391223|2890350 |
| C047948 | 1'-acetoxychavicol acetate | 1'-acetoxychavicol acetate inhibits the reaction [TNF protein results in increased expression of BIRC5 protein] | 15905586 |
| C029790 | 2,2',3',4,4',5-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BIRC5 mRNA" | 25510870 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | "2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naphtho(1,2-b)furan-4,5-dione results in decreased expression of BIRC5 protein]" | 19747539 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in decreased expression of BIRC5 protein] | 18377872 |
| C093973 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one results in decreased expression of BIRC5 protein | 18710790 |
| C111118 | 2',3,3',4',5-pentachloro-4-hydroxybiphenyl | "2',3,3',4',5-pentachloro-4-hydroxybiphenyl results in decreased expression of BIRC5 mRNA" | 19114083 |
| C029497 | 2,3-bis(3'-hydroxybenzyl)butyrolactone | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BIRC5 mRNA" | 19167446 |
| C063002 | 2,3-dimethoxy-1,4-naphthoquinone | "2,3-dimethoxy-1,4-naphthoquinone results in increased expression of BIRC5 mRNA" | 19031421 |
| C081766 | 2,4,4'-trichlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BIRC5 mRNA" | 25510870 |
| C014024 | 2,4,5,2',4',5'-hexachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BIRC5 mRNA" | 25510870 |
| C009828 | 2,4,5,2',5'-pentachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BIRC5 mRNA" | 25510870 |
| C562254 | 2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione | "2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in decreased expression of BIRC5 protein" | 21741372 |
| C562254 | 2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione | "Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in decreased expression of BIRC5 protein]" | 21741372 |
| C010914 | 2,4-diaminotoluene | "2,4-diaminotoluene results in increased expression of BIRC5 mRNA" | 20713471 |
| C059354 | 2',4'-dihydroxychalcone | "2',4'-dihydroxychalcone results in decreased expression of BIRC5 mRNA" | 20471467 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of BIRC5 mRNA | 22046442 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of BIRC5 protein | 22046442 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [CALCA protein results in increased expression of BIRC5 protein] | 16222118 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [arsenic trioxide results in decreased expression of BIRC5 protein] | 21594580 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Simvastatin results in decreased expression of BIRC5 protein] | 20464445 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BIRC5 mRNA | 15065019 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BIRC5 protein | 15065019|1747296 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in increased expression of BIRC5 mRNA | 22046442 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | Simvastatin promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BIRC5 protein] | 20464445 |
| C085911 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cisplatin results in increased expression of BIRC5 mRNA] | 20514400 |
| C009407 | 2,5,2',5'-tetrachlorobiphenyl | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BIRC5 mRNA" | 25510870 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in decreased expression of BIRC5 protein" | 18444175 |
| C488288 | 2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid | "2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid results in decreased expression of BIRC5 protein" | 18444175 |
| C506698 | 2,5-dimethylcelecoxib | "2,5-dimethylcelecoxib results in decreased expression of BIRC5 protein" | 16123214|1670702 |
| C557882 | 25-methoxyldammarane-3,12,20-triol | "25-methoxyldammarane-3,12,20-triol results in decreased expression of BIRC5 protein" | 21924252 |
| C003898 | 2-anisidine | 2-anisidine results in decreased expression of BIRC5 mRNA | 28089782 |
| C526437 | 2-methoxy-3-O-sulfamoyl-17-cyanomethylestra-1,3,5(10)-triene | "2-methoxy-3-O-sulfamoyl-17-cyanomethylestra-1,3,5(10)-triene results in decreased expression of BIRC5 protein" | 19846905 |
| C526438 | 2-methoxyestradiol-3,17-O,O-bis(sulfamate) | "2-methoxyestradiol-3,17-O,O-bis(sulfamate) results in decreased expression of BIRC5 protein" | 19846905 |
| C511621 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Particulate Matter results in decreased expression of BIRC5 mRNA] | 28655636 |
| C511621 | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Vehicle Emissions results in decreased expression of BIRC5 mRNA] | 28655636 |
| C016392 | 3,3'-diindolylmethane | "3,3'-diindolylmethane results in decreased expression of BIRC5 protein" | 22290291 |
| C482492 | 3,4,5,4'-tetramethoxystilbene | "3,4,5,4'-tetramethoxystilbene results in decreased expression of BIRC5 protein" | 23770989 |
| C524042 | 3,5-bis(2-fluorobenzylidene)piperidin-4-one | "3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein]" | 23452621 |
| C000602001 | 4-(3,5-dimethoxystyryl)phenyl acetate | "4-(3,5-dimethoxystyryl)phenyl acetate results in decreased expression of BIRC5 protein" | 26138072 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | "4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [betulinic acid results in increased expression of BIRC5]" | 16077934 |
| C088860 | 4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline | "4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Paclitaxel results in increased expression of BIRC5]" | 16211241 |
| C009505 | 4,4'-diaminodiphenylmethane | "4,4'-diaminodiphenylmethane results in increased expression of BIRC5 mRNA" | 18648102 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Nitroprusside results in decreased expression of BIRC5 protein] | 14988404 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [oxaliplatin results in decreased expression of BIRC5 protein] | 20708607 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [S-nitro-N-acetylpenicillamine results in decreased expression of BIRC5 protein] | 14988404 |
| C090942 | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole affects the reaction [BIRC5 protein results in decreased susceptibility to oxaliplatin] | 20708607 |
| C459179 | 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BIRC5 mRNA" | 27188386 |
| C506606 | 4-(6-cyclohexylmethoxy-9H-purin-2-ylamino)-N,N-diethylbenzamide | "[4-(6-cyclohexylmethoxy-9H-purin-2-ylamino)-N,N-diethylbenzamide co-treated with Paclitaxel] results in decreased expression of BIRC5 protein" | 16170024 |
| C506606 | 4-(6-cyclohexylmethoxy-9H-purin-2-ylamino)-N,N-diethylbenzamide | "4-(6-cyclohexylmethoxy-9H-purin-2-ylamino)-N,N-diethylbenzamide results in decreased expression of BIRC5 protein" | 16170024 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in decreased expression of BIRC5 mRNA | 19191707 |
| C027576 | 4-hydroxy-2-nonenal | 4-hydroxy-2-nonenal results in increased expression of BIRC5 mRNA | 19191707 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone affects the localization of and results in increased expression of BIRC5 protein | 21776270 |
| C016583 | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone | 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in decreased expression of BIRC5 mRNA | 21167638 |
| C546624 | (5-(2,4-bis((3S)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol | "(5-(2,4-bis((3S)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol inhibits the reaction [N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide results in increased expression of and affects the localization of BIRC5 protein]" | 24444656 |
| C580598 | 5-OH-BDE-47 | 5-OH-BDE-47 results in decreased expression of BIRC5 mRNA | 27589474 |
| C471843 | 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine | 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine promotes the reaction [Nitroprusside results in decreased expression of BIRC5 mRNA] | 14988404 |
| C471843 | 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine | 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine results in decreased expression of BIRC5 protein | 15958644|1617002 |
| C516138 | (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BIRC5 mRNA" | 27188386 |
| C560597 | 6,7-epoxy-5,17-dihydroxy-1-oxowitha-2,24-dienolide | "6,7-epoxy-5,17-dihydroxy-1-oxowitha-2,24-dienolide binds to and results in decreased activity of BIRC5 protein" | 23994265 |
| C580599 | 6-OH-BDE-47 | 6-OH-BDE-47 results in decreased expression of BIRC5 mRNA | 27589474 |
| C054852 | 7-hydroxystaurosporine | [alvocidib co-treated with 7-hydroxystaurosporine] results in decreased expression of BIRC5 protein | 16012789 |
| C054852 | 7-hydroxystaurosporine | BIRC5 protein results in decreased susceptibility to 7-hydroxystaurosporine | 16012789 |
| C542662 | AC 93253 | AC 93253 results in decreased expression of BIRC5 mRNA | 25912555 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of BIRC5 mRNA | 29067470 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of BIRC5 mRNA | 22230336 |
| D000082 | Acetaminophen | Acetaminophen results in decreased expression of BIRC5 mRNA | 17942131 |
| D000082 | Acetaminophen | Acetaminophen results in increased expression of BIRC5 protein | 20100502 |
| D000082 | Acetaminophen | CAV1 affects the reaction [Acetaminophen results in increased expression of BIRC5 protein] | 20100502 |
| D000111 | Acetylcysteine | "Acetylcysteine inhibits the reaction [2'-(4-chlorophenyl)-3-(4-chlorophenylidene)-5,10-dimethyl-12-methylene-decahydro-1,2-(1',3'-dioxocyclopenta(c))azuleno(4,5-b)furan-4,11-dione results in decreased expression of BIRC5 protein]" | 21741372 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [gingerol results in decreased expression of BIRC5 protein] | 25034532 |
| D000111 | Acetylcysteine | Acetylcysteine inhibits the reaction [TNFSF10 protein results in decreased expression of BIRC5 protein] | 23711929 |
| D020106 | Acrylamide | Acrylamide results in increased expression of BIRC5 mRNA | 28959563 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 affects the expression of BIRC5 protein | 20106945 |
| D016604 | Aflatoxin B1 | Aflatoxin B1 results in decreased expression of BIRC5 mRNA | 19770486 |
| C038491 | allyl sulfide | allyl sulfide results in decreased expression of BIRC5 protein | 17647244 |
| C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased expression of BIRC5 mRNA" | 24587049 |
| C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | "alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased expression of BIRC5 protein" | 20197088|2458704 |
| C095512 | alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide | "[alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide results in decreased phosphorylation of STAT3 protein] which results in decreased expression of BIRC5 protein" | 18592012 |
| C077990 | alvocidib | [alvocidib co-treated with 7-hydroxystaurosporine] results in decreased expression of BIRC5 protein | 16012789 |
| C077990 | alvocidib | [alvocidib co-treated with PBOX-6] results in decreased expression of BIRC5 protein | 20206141 |
| C077990 | alvocidib | alvocidib inhibits the reaction [Doxorubicin results in increased expression of and results in increased phosphorylation of BIRC5 protein] | 12517802 |
| C077990 | alvocidib | alvocidib results in decreased expression of BIRC5 | 16820931 |
| C077990 | alvocidib | alvocidib results in decreased expression of BIRC5 mRNA | 12517783 |
| C077990 | alvocidib | alvocidib results in decreased expression of BIRC5 protein | 12517783 |
| C077990 | alvocidib | alvocidib results in decreased phosphorylation of and results in decreased expression of BIRC5 protein | 12517802 |
| D000638 | Amiodarone | Amiodarone results in decreased expression of BIRC5 protein | 21224497 |
| C059765 | amphotericin B, deoxycholate drug combination | "amphotericin B, deoxycholate drug combination results in increased expression of BIRC5 mRNA" | 22863853 |
| C088115 | anacardic acid | anacardic acid inhibits the reaction [TNF protein results in increased expression of BIRC5 protein] | 18349320 |
| C030419 | andrographolide | andrographolide results in decreased expression of BIRC5 protein | 23845849 |
| D000841 | Anisomycin | Anisomycin promotes the reaction [(+)-JQ1 compound results in decreased expression of BIRC5 protein] | 23872705 |
| C558369 | antrocin | antrocin results in decreased expression of BIRC5 mRNA | 21158420 |
| C558369 | antrocin | antrocin results in decreased expression of BIRC5 protein | 21158420 |
| D001151 | Arsenic | [Arsenic co-treated with Fluorides] results in increased expression of BIRC5 mRNA | 19962721 |
| C058317 | arsenic disulfide | arsenic disulfide results in decreased expression of BIRC5 | 15972126 |
| C006632 | arsenic trioxide | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [arsenic trioxide results in decreased expression of BIRC5 protein] | 21594580 |
| C006632 | arsenic trioxide | arsenic trioxide affects the expression of BIRC5 mRNA | 18088464 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with Curcumin] results in decreased expression of BIRC5 protein | 27430728 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BIRC5 mRNA | 24738333 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BIRC5 protein | 24738333 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with Ethacrynic Acid] results in decreased expression of BIRC5 protein | 23082001 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with Oxygen deficiency] results in decreased expression of BIRC5 mRNA | 19825857 |
| C006632 | arsenic trioxide | [arsenic trioxide co-treated with Oxygen deficiency] results in decreased expression of BIRC5 protein | 19825857 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [matrine results in decreased expression of BIRC5 protein] | 23700110 |
| C006632 | arsenic trioxide | arsenic trioxide promotes the reaction [puerarin results in decreased expression of BIRC5 mRNA] | 20416161 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of BIRC5 | 21473291 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of BIRC5 mRNA | 16638212|1786904 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of BIRC5 protein | 16328441|1663821 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of BIRC5 mRNA | 15587394 |
| C006632 | arsenic trioxide | arsenic trioxide results in increased expression of BIRC5 protein | 15587394|2743072 |
| C006632 | arsenic trioxide | [arsenic trioxide results in increased susceptibility to PD 173074] which results in decreased expression of BIRC5 protein | 27794399 |
| C006632 | arsenic trioxide | BIRC5 protein affects the susceptibility to arsenic trioxide | 20635649 |
| C006632 | arsenic trioxide | BIRC5 protein results in decreased susceptibility to arsenic trioxide | 15587394|2743072 |
| C006632 | arsenic trioxide | GH1 protein promotes the reaction [arsenic trioxide results in decreased expression of BIRC5 mRNA] | 23851143 |
| C006632 | arsenic trioxide | matrine promotes the reaction [arsenic trioxide results in decreased expression of BIRC5 protein] | 23700110 |
| C006632 | arsenic trioxide | Poly I-C promotes the reaction [arsenic trioxide results in decreased expression of BIRC5 protein] | 21418039 |
| C006632 | arsenic trioxide | pyrazolanthrone inhibits the reaction [arsenic trioxide results in decreased expression of BIRC5 protein] | 16328441|2159458 |
| C006632 | arsenic trioxide | SB 203580 inhibits the reaction [arsenic trioxide results in decreased expression of BIRC5 protein] | 16328441|2159458 |
| C006632 | arsenic trioxide | [silybin co-treated with arsenic trioxide] results in decreased expression of BIRC5 mRNA | 21969006 |
| C006632 | arsenic trioxide | [Sulindac co-treated with arsenic trioxide] results in decreased expression of BIRC5 protein | 18281123 |
| C006632 | arsenic trioxide | U 0126 inhibits the reaction [arsenic trioxide results in decreased expression of BIRC5 protein] | 21594580 |
| C006632 | arsenic trioxide | "arsenic trioxide promotes the reaction [Drugs, Chinese Herbal results in decreased expression of BIRC5 protein]" | 28587418 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of BIRC5 protein | 28587418 |
| C006632 | arsenic trioxide | "Drugs, Chinese Herbal promotes the reaction [arsenic trioxide results in decreased expression of BIRC5 protein]" | 28587418 |
| C006632 | arsenic trioxide | arsenic trioxide results in decreased expression of BIRC5 protein | 23444241 |
| C015001 | arsenite | arsenite results in decreased expression of BIRC5 mRNA | 18585952 |
| C015001 | arsenite | XPA protein affects the reaction [arsenite results in decreased expression of BIRC5 mRNA] | 18585952 |
| C015001 | arsenite | arsenite results in decreased expression of BIRC5 mRNA | 18929588 |
| C519899 | AS602868 | AS602868 results in decreased expression of BIRC5 mRNA | 18182997 |
| C519899 | AS602868 | irinotecan promotes the reaction [AS602868 results in decreased expression of BIRC5 mRNA] | 18182997 |
| D001205 | Ascorbic Acid | Ascorbic Acid results in decreased expression of BIRC5 mRNA | 21919647 |
| D001241 | Aspirin | [Aspirin co-treated with TNFSF10 protein] results in decreased expression of BIRC5 protein | 18483385 |
| D001241 | Aspirin | Aspirin inhibits the reaction [E2F1 protein binds to BIRC5 promoter] | 17848598 |
| D001241 | Aspirin | Aspirin results in decreased expression of BIRC5 mRNA | 17848598 |
| D001241 | Aspirin | Aspirin results in decreased expression of BIRC5 protein | 17848598|1848338 |
| D001241 | Aspirin | Aspirin results in increased expression of BIRC5 mRNA | 11906190|1734232 |
| D001241 | Aspirin | epoxomicin inhibits the reaction [Aspirin results in decreased expression of BIRC5 protein] | 18483385 |
| D001241 | Aspirin | Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein] | 25449198 |
| D000069059 | Atorvastatin Calcium | Atorvastatin Calcium results in decreased expression of BIRC5 mRNA | 17372815 |
| D000069059 | Atorvastatin Calcium | Atorvastatin Calcium results in decreased expression of BIRC5 protein | 17372815 |
| D001280 | Atrazine | Atrazine results in decreased expression of BIRC5 mRNA | 22378314 |
| C010329 | azadirachtin | azadirachtin results in decreased expression of BIRC5 protein | 20429769 |
| D001379 | Azathioprine | Azathioprine results in decreased expression of BIRC5 mRNA | 22623647 |
| C547126 | AZM551248 | AZM551248 results in increased expression of BIRC5 mRNA | 22323515 |
| D001397 | Azoxymethane | Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein] | 25449198 |
| D001397 | Azoxymethane | [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein | 25449198 |
| D001397 | Azoxymethane | Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein] | 25449198 |
| D001397 | Azoxymethane | Plant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein] | 25449198 |
| C006680 | baicalein | baicalein results in decreased expression of BIRC5 protein | 18025287 |
| C006680 | baicalein | SB 203580 inhibits the reaction [baicalein results in decreased expression of BIRC5 protein] | 18025287 |
| C006680 | baicalein | wortmannin promotes the reaction [baicalein results in decreased expression of BIRC5 protein] | 18025287 |
| C012765 | bakuchiol | bakuchiol results in decreased expression of BIRC5 protein | 27033605 |
| C487081 | belinostat | belinostat results in decreased expression of BIRC5 mRNA | 19606018 |
| C030935 | benz(a)anthracene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BIRC5 mRNA | 27858113 |
| C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene affects the localization of and results in increased expression of BIRC5 protein | 21776270 |
| C006703 | benzo(b)fluoranthene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BIRC5 mRNA | 27858113 |
| C006703 | benzo(b)fluoranthene | benzo(b)fluoranthene results in increased expression of BIRC5 mRNA | 26377693 |
| D019324 | beta-Naphthoflavone | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BIRC5 mRNA | 18164116 |
| D019817 | Benzoic Acid | Benzoic Acid analog inhibits the reaction [STAT3 protein binds to BIRC5 promoter] | 26088127 |
| C022921 | benzo(k)fluoranthene | benzo(k)fluoranthene results in increased expression of BIRC5 mRNA | 26377693 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of BIRC5 mRNA | 20064835|2163298 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of BIRC5 protein | 24664296 |
| D001564 | Benzo(a)pyrene | Curcumin inhibits the reaction [Benzo(a)pyrene results in decreased expression of BIRC5 protein] | 24664296 |
| D001564 | Benzo(a)pyrene | Vitamin E inhibits the reaction [Benzo(a)pyrene results in decreased expression of BIRC5 protein] | 24664296 |
| D001564 | Benzo(a)pyrene | AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of BIRC5 mRNA] | 15034205 |
| D001564 | Benzo(a)pyrene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BIRC5 mRNA | 27858113 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in decreased expression of BIRC5 mRNA | 15034205|1794213 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of BIRC5 mRNA | 21964900|2649674 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of BIRC5 mRNA" | 20382639 |
| D015123 | 7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide | "7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in increased expression of BIRC5 mRNA" | 19150397 |
| D003374 | Coumarins | Coumarins analog results in decreased expression of BIRC5 protein | 25231984 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Capsaicin results in decreased expression of BIRC5 protein] | 19939880 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [(+)-JQ1 compound results in decreased expression of BIRC5 protein] | 23872705 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[pifithrin co-treated with Topotecan] results in increased degradation of BIRC5 protein] | 19812371 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Quercetin results in decreased expression of BIRC5 protein] | 17548900 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased susceptibility to [oxaliplatin results in decreased expression of BIRC5 protein] | 20708607 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in increased expression of BIRC5 protein | 16328441|1751042 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Topotecan results in increased degradation of BIRC5 protein] | 19812371 |
| C072553 | benzyloxycarbonylleucyl-leucyl-leucine aldehyde | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased expression of BIRC5 mRNA | 25566086 |
| C027870 | berbamine | berbamine binds to BIRC5 promoter | 17968851 |
| C027870 | berbamine | berbamine results in decreased expression of BIRC5 mRNA | 17531122 |
| C027870 | berbamine | berbamine results in decreased expression of BIRC5 protein | 19960011 |
| D001599 | Berberine | Berberine binds to BIRC5 promoter | 17968851 |
| D004958 | Estradiol | Estradiol affects the expression of BIRC5 mRNA | 21826169 |
| D004958 | Estradiol | Estradiol inhibits the reaction [Etoposide results in increased expression of BIRC5 mRNA] | 19426747 |
| D004958 | Estradiol | Estradiol results in decreased expression of BIRC5 mRNA | 19426747 |
| D004958 | Estradiol | Estradiol results in increased expression of BIRC5 mRNA | 16474171|1670574 |
| D004958 | Estradiol | ESR1 protein promotes the reaction [Estradiol results in increased expression of BIRC5 mRNA] | 25210133 |
| D004958 | Estradiol | Estradiol results in increased expression of BIRC5 mRNA | 25210133 |
| D004958 | Estradiol | Estradiol results in increased expression of BIRC5 mRNA | 21980073 |
| C044887 | beta-methylcholine | beta-methylcholine affects the expression of BIRC5 mRNA | 21179406 |
| C002503 | betulin | betulin analog promotes the reaction [Oxygen deficiency results in decreased expression of BIRC5 protein] | 26540049 |
| C002503 | betulin | betulin analog results in decreased expression of BIRC5 protein | 26540049 |
| C002070 | betulinic acid | "4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [betulinic acid results in increased expression of BIRC5]" | 16077934 |
| C002070 | betulinic acid | betulinic acid promotes the reaction [Oxygen deficiency results in decreased expression of BIRC5 protein] | 26540049 |
| C002070 | betulinic acid | betulinic acid results in decreased expression of BIRC5 protein | 26540049 |
| C002070 | betulinic acid | betulinic acid results in increased expression of BIRC5 | 16077934 |
| C002070 | betulinic acid | BIRC5 protein results in decreased susceptibility to betulinic acid | 16077934 |
| C095105 | bexarotene | bexarotene results in decreased expression of BIRC5 protein | 19067706 |
| C095105 | bexarotene | bexarotene results in decreased expression of BIRC5 mRNA | 17849452 |
| C053541 | bicalutamide | bicalutamide results in decreased expression of BIRC5 mRNA | 15638997 |
| C543008 | bis(4-hydroxyphenyl)sulfone | bis(4-hydroxyphenyl)sulfone results in increased expression of BIRC5 mRNA | 27685785 |
| C543008 | bis(4-hydroxyphenyl)sulfone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of BIRC5 mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of BIRC5 mRNA | 27561114 |
| C006780 | bisphenol A | bisphenol A affects the expression of BIRC5 mRNA | 21826169 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of BIRC5 mRNA | 27979917|2927551 |
| C006780 | bisphenol A | bisphenol A results in increased expression of BIRC5 mRNA | 16474171 |
| C006780 | bisphenol A | bisphenol A results in increased expression of BIRC5 protein | 19270784 |
| C006780 | bisphenol A | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BIRC5 mRNA | 28628672 |
| C006780 | bisphenol A | bisphenol A results in increased expression of BIRC5 mRNA | 27623287 |
| C006780 | bisphenol A | bisphenol A results in decreased expression of BIRC5 mRNA | 25181051 |
| C006780 | bisphenol A | bisphenol A results in increased expression of BIRC5 mRNA | 18180321 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in decreased expression of BIRC5 mRNA | 17942131 |
| C005961 | bis(tri-n-butyltin)oxide | bis(tri-n-butyltin)oxide results in decreased expression of BIRC5 mRNA | 17553608 |
| D001761 | Bleomycin | Bleomycin results in increased expression of BIRC5 mRNA | 26345256 |
| D000069286 | Bortezomib | Bortezomib results in decreased expression of BIRC5 mRNA | 17898295|2097792 |
| D000069286 | Bortezomib | Bortezomib results in decreased expression of BIRC5 protein | 18850583|1963629 |
| D000069286 | Bortezomib | Bortezomib results in increased expression of BIRC5 protein | 17510429 |
| D000069286 | Bortezomib | [irinotecan co-treated with Bortezomib] results in decreased expression of BIRC5 protein | 16373703 |
| D000069286 | Bortezomib | [romidepsin co-treated with Bortezomib] results in increased cleavage of BIRC5 protein | 18223231 |
| D000069286 | Bortezomib | Bortezomib results in decreased expression of BIRC5 protein | 18451165 |
| C000595192 | BP-1-102 | BP-1-102 analog inhibits the reaction [STAT3 protein binds to BIRC5 promoter] | 26088127 |
| C000595192 | BP-1-102 | BP-1-102 analog results in decreased expression of BIRC5 protein | 26088127 |
| D001973 | Bromodeoxyuridine | [Bromodeoxyuridine co-treated with furan] results in increased expression of BIRC5 mRNA | 24910943 |
| C514835 | bromotetrandrine | [bromotetrandrine co-treated with Daunorubicin] results in decreased expression of BIRC5 mRNA | 21362215 |
| C514835 | bromotetrandrine | [bromotetrandrine co-treated with Daunorubicin] results in decreased expression of BIRC5 protein | 21362215 |
| C514835 | bromotetrandrine | [Daunorubicin co-treated with bromotetrandrine co-treated with Magnetite Nanoparticles] results in decreased expression of BIRC5 mRNA | 21720514 |
| C514835 | bromotetrandrine | [Daunorubicin co-treated with bromotetrandrine co-treated with Magnetite Nanoparticles] results in decreased expression of BIRC5 protein | 21720514 |
| C514835 | bromotetrandrine | [Daunorubicin co-treated with bromotetrandrine] results in decreased expression of BIRC5 mRNA | 21720514 |
| C514835 | bromotetrandrine | [Daunorubicin co-treated with bromotetrandrine] results in decreased expression of BIRC5 protein | 21720514 |
| D019819 | Budesonide | Budesonide results in decreased expression of BIRC5 mRNA | 17163412 |
| C048491 | butaprost | butaprost inhibits the reaction [[Indomethacin results in decreased activity of PTGS2 protein] which results in decreased expression of BIRC5 protein] | 21268125 |
| C048491 | butaprost | butaprost results in increased expression of BIRC5 protein | 21268125 |
| D020122 | tert-Butylhydroperoxide | tert-Butylhydroperoxide results in increased expression of BIRC5 mRNA | 15003993 |
| D002085 | Butylhydroxybutylnitrosamine | [Butylhydroxybutylnitrosamine co-treated with Propolis analog] results in increased expression of BIRC5 mRNA | 26111810 |
| D002087 | Butyrates | [Butyrates co-treated with Camptothecin] results in decreased expression of BIRC5 protein | 16061681 |
| D002087 | Butyrates | Butyrates results in decreased expression of BIRC5 mRNA | 16042588 |
| D002087 | Butyrates | Butyrates results in decreased expression of BIRC5 protein | 16007142 |
| D002166 | Camptothecin | [Butyrates co-treated with Camptothecin] results in decreased expression of BIRC5 protein | 16061681 |
| D002166 | Camptothecin | Camptothecin results in decreased expression of BIRC5 mRNA | 24726431 |
| D002166 | Camptothecin | Camptothecin results in increased expression of BIRC5 mRNA | 24726431 |
| D002166 | Camptothecin | Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein] | 25449198 |
| D002193 | Cantharidin | Cantharidin results in decreased expression of BIRC5 protein | 16117893 |
| C464842 | Canvaxin | BIRC5 results in decreased susceptibility to Canvaxin | 15986442 |
| D002211 | Capsaicin | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Capsaicin results in decreased expression of BIRC5 protein] | 19939880 |
| D002211 | Capsaicin | BIRC5 results in decreased activity of [Capsaicin co-treated with TNFSF10 protein] | 19939880 |
| D002211 | Capsaicin | Capsaicin results in decreased expression of BIRC5 | 19002586 |
| D002211 | Capsaicin | Capsaicin results in decreased expression of BIRC5 protein | 17505005|1993988 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of BIRC5 mRNA | 17484886|2733941 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of BIRC5 protein | 17484886 |
| D000068579 | Celecoxib | BIRC5 protein inhibits the reaction [Celecoxib results in increased activity of CASP3 protein] | 17466271 |
| D000068579 | Celecoxib | Celecoxib binds to BIRC5 promoter | 17466271 |
| D000068579 | Celecoxib | [Celecoxib binds to BIRC5 promoter] which results in decreased expression of BIRC5 mRNA | 17466271|1746627 |
| D000068579 | Celecoxib | Celecoxib results in decreased expression of BIRC5 mRNA | 17270149|1746627 |
| D000068579 | Celecoxib | Celecoxib results in decreased expression of BIRC5 protein | 16004971|1612321 |
| D000068579 | Celecoxib | Celecoxib results in increased expression of BIRC5 mRNA | 17342322 |
| D000068579 | Celecoxib | [Celecoxib results in decreased activity of PTGS2 protein] which results in decreased expression of BIRC5 protein | 21268125 |
| D000068579 | Celecoxib | Celecoxib results in decreased expression of BIRC5 mRNA | 17717820 |
| D002699 | Chlorambucil | Chlorambucil affects the expression of BIRC5 mRNA | 17476690 |
| D002706 | Chlordan | Chlordan results in increased expression of BIRC5 mRNA | 20403969 |
| D002738 | Chloroquine | Chloroquine promotes the reaction [sunitinib results in decreased expression of BIRC5 protein] | 24751611 |
| D002746 | Chlorpromazine | Chlorpromazine analog results in decreased expression of BIRC5 mRNA | 15924885 |
| C031180 | chrysene | [Benzo(a)pyrene co-treated with benz(a)anthracene co-treated with benzo(b)fluoranthene co-treated with chrysene] results in increased expression of BIRC5 mRNA | 27858113 |
| C011585 | ciclopirox | ciclopirox results in decreased expression of BIRC5 mRNA | 19589922 |
| C011585 | ciclopirox | ciclopirox results in decreased expression of BIRC5 protein | 19589922 |
| C039671 | ciglitazone | ciglitazone results in decreased expression of BIRC5 | 17940898 |
| C002471 | cinobufagin | cinobufagin results in decreased expression of BIRC5 protein | 23164673 |
| D003033 | Coal Tar | Coal Tar results in decreased expression of BIRC5 mRNA | 27858113 |
| C018021 | cobaltous chloride | cobaltous chloride results in decreased expression of BIRC5 mRNA | 19320972|1937684 |
| D003300 | Copper | [NSC 689534 binds to Copper] which results in decreased expression of BIRC5 mRNA | 20971185 |
| C464760 | copper-1,10-phenanthroline | "copper-1,10-phenanthroline results in decreased expression of BIRC5 protein" | 24638265 |
| D019327 | Copper Sulfate | Copper Sulfate results in decreased expression of BIRC5 mRNA | 19549813 |
| C113861 | corosolic acid | corosolic acid results in increased expression of BIRC5 protein | 28506699 |
| D003375 | Coumestrol | "[Coumestrol co-treated with 2,3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of BIRC5 mRNA" | 19167446 |
| D003375 | Coumestrol | [Coumestrol co-treated with resveratrol] results in increased expression of BIRC5 mRNA | 19167446 |
| D003375 | Coumestrol | Coumestrol results in increased expression of BIRC5 mRNA | 19167446 |
| C551994 | crizotinib | crizotinib results in decreased expression of BIRC5 protein | 22729845 |
| C551994 | crizotinib | MET gene mutant form promotes the reaction [crizotinib results in increased expression of BIRC5 protein] | 22729845 |
| C551994 | crizotinib | crizotinib results in decreased expression of BIRC5 | 21716144 |
| D003474 | Curcumin | [arsenic trioxide co-treated with Curcumin] results in decreased expression of BIRC5 protein | 27430728 |
| D003474 | Curcumin | Curcumin analog results in decreased expression of BIRC5 mRNA | 17671737|2640932 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Benzo(a)pyrene results in decreased expression of BIRC5 protein] | 24664296 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Nicotine results in increased expression of BIRC5 protein] | 20727180 |
| D003474 | Curcumin | Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein] | 23452621 |
| D003474 | Curcumin | Curcumin results in decreased expression of BIRC5 mRNA | 17596214|1767173 |
| D003474 | Curcumin | Curcumin results in decreased expression of BIRC5 protein | 16023083|1859393 |
| D003474 | Curcumin | [Curcumin co-treated with gemcitabine] results in decreased expression of BIRC5 protein | 17440100 |
| C038459 | curdlan | curdlan results in decreased expression of BIRC5 mRNA | 23543010 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of BIRC5 mRNA | 20106945|2163298 |
| D016572 | Cyclosporine | Cyclosporine results in decreased expression of BIRC5 mRNA | 17942131 |
| C463260 | D-65476 | FLT3 gene mutant form promotes the reaction [[D-65476 co-treated with Tretinoin] results in decreased expression of BIRC5 mRNA] | 16473406 |
| C463260 | D-65476 | FLT3 gene mutant form promotes the reaction [[D-65476 co-treated with Tretinoin] results in decreased expression of BIRC5 protein] | 16473406 |
| D003606 | Dacarbazine | Dacarbazine results in increased expression of BIRC5 protein | 15577328 |
| C531198 | dactolisib | dactolisib results in decreased expression of BIRC5 protein | 22729845 |
| C004315 | danthron | danthron results in decreased expression of BIRC5 protein | 21126053 |
| D000069439 | Dasatinib | Dasatinib results in decreased expression of BIRC5 mRNA | 20579391 |
| D003630 | Daunorubicin | [bromotetrandrine co-treated with Daunorubicin] results in decreased expression of BIRC5 mRNA | 21362215 |
| D003630 | Daunorubicin | [bromotetrandrine co-treated with Daunorubicin] results in decreased expression of BIRC5 protein | 21362215 |
| D003630 | Daunorubicin | Daunorubicin affects the expression of BIRC5 mRNA | 16638212 |
| D003630 | Daunorubicin | [Daunorubicin co-treated with bromotetrandrine co-treated with Magnetite Nanoparticles] results in decreased expression of BIRC5 mRNA | 21720514 |
| D003630 | Daunorubicin | [Daunorubicin co-treated with bromotetrandrine co-treated with Magnetite Nanoparticles] results in decreased expression of BIRC5 protein | 21720514 |
| D003630 | Daunorubicin | [Daunorubicin co-treated with bromotetrandrine] results in decreased expression of BIRC5 mRNA | 21720514 |
| D003630 | Daunorubicin | [Daunorubicin co-treated with bromotetrandrine] results in decreased expression of BIRC5 protein | 21720514 |
| D003630 | Daunorubicin | Daunorubicin results in increased expression of BIRC5 mRNA | 27780733 |
| D003630 | Daunorubicin | Daunorubicin results in increased expression of BIRC5 protein | 16638212 |
| C010902 | decabromobiphenyl ether | decabromobiphenyl ether results in decreased expression of BIRC5 mRNA | 26206603 |
| C014347 | decitabine | decitabine affects the expression of BIRC5 protein | 18636160 |
| C014347 | decitabine | decitabine inhibits the reaction [trichostatin A results in decreased expression of BIRC5 mRNA] | 18718068 |
| C014347 | decitabine | decitabine results in decreased expression of BIRC5 mRNA | 19363521 |
| C014347 | decitabine | decitabine results in decreased expression of BIRC5 protein | 19363521 |
| C014347 | decitabine | decitabine results in decreased methylation of BIRC5 promoter | 19363521 |
| C014347 | decitabine | TP53 protein affects the reaction [decitabine results in decreased expression of BIRC5 mRNA] | 19363521 |
| C014347 | decitabine | TP53 protein affects the reaction [decitabine results in decreased expression of BIRC5 protein] | 19363521 |
| C107676 | deguelin | deguelin inhibits the reaction [docetaxel results in increased expression of BIRC5 protein] | 17035597 |
| C107676 | deguelin | deguelin inhibits the reaction [Doxorubicin results in increased expression of BIRC5 protein] | 17035597 |
| C107676 | deguelin | deguelin results in decreased expression of BIRC5 protein | 17035597|1859336 |
| C464444 | dehydroxymethylepoxyquinomicin | [dehydroxymethylepoxyquinomicin co-treated with TNF protein] results in decreased expression of BIRC5 | 16211219 |
| D013759 | Dronabinol | CDK1 inhibits the reaction [Dronabinol results in decreased expression of BIRC5 protein] | 16818634 |
| D013759 | Dronabinol | Dronabinol results in decreased expression of BIRC5 protein | 16818634 |
| C040424 | destruxin B | destruxin B results in decreased expression of BIRC5 protein | 22465936|2443401 |
| D003907 | Dexamethasone | Dexamethasone affects the expression of BIRC5 | 21244764 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of BIRC5 mRNA | 28628672 |
| D003907 | Dexamethasone | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BIRC5 mRNA | 28628672 |
| D003907 | Dexamethasone | Mifepristone inhibits the reaction [Dexamethasone results in increased expression of BIRC5] | 21244764 |
| D003907 | Dexamethasone | [PDCD5 protein co-treated with Dexamethasone] results in decreased expression of BIRC5 | 20693715 |
| D016264 | Dextran Sulfate | Aspirin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein] | 25449198 |
| D016264 | Dextran Sulfate | [Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein | 25449198 |
| D016264 | Dextran Sulfate | Camptothecin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein] | 25449198 |
| D016264 | Dextran Sulfate | Plant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein] | 25449198 |
| C028009 | diallyl disulfide | diallyl disulfide results in decreased expression of BIRC5 protein | 17647244 |
| C042577 | diallyl trisulfide | diallyl trisulfide results in decreased expression of BIRC5 protein | 23754639 |
| C042577 | diallyl trisulfide | diallyl trisulfide results in increased expression of BIRC5 mRNA | 21411500 |
| C042577 | diallyl trisulfide | diallyl trisulfide results in increased expression of BIRC5 protein | 21411500 |
| C042577 | diallyl trisulfide | diallyl trisulfide results in increased expression of BIRC5 protein | 21411500 |
| C038867 | diazene | diazene analog affects the expression of BIRC5 | 16061352 |
| D003976 | Diazinon | Diazinon results in decreased expression of BIRC5 mRNA | 27920530 |
| D003976 | Diazinon | Magnesium Oxide analog inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA] | 27920530 |
| D003976 | Diazinon | [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA] | 27920530 |
| D003976 | Diazinon | Selenium analog inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA] | 27920530 |
| D003976 | Diazinon | Diazinon affects the expression of BIRC5 mRNA | 22546817 |
| C041517 | dibenzo(a,l)pyrene | "dibenzo(a,l)pyrene results in decreased expression of BIRC5 mRNA" | 26496743 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of BIRC5 mRNA | 28973377 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of BIRC5 mRNA | 17361019 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in decreased expression of BIRC5 mRNA | 21266533 |
| D003993 | Dibutyl Phthalate | Dibutyl Phthalate results in increased expression of BIRC5 mRNA | 17379624 |
| D003999 | Dichloroacetic Acid | Dichloroacetic Acid results in increased expression of BIRC5 mRNA | 28962523 |
| D002945 | Cisplatin | BIRC5 protein results in decreased susceptibility to Cisplatin | 11911975|1465491 |
| D002945 | Cisplatin | BIRC5 protein results in decreased susceptibility to [Cisplatin co-treated with Etoposide] | 15917659|1638289 |
| D002945 | Cisplatin | [Cisplatin co-treated with fisetin] results in decreased expression of BIRC5 protein | 21216935 |
| D002945 | Cisplatin | [Cisplatin co-treated with jinfukang] results in decreased expression of BIRC5 mRNA | 27392435 |
| D002945 | Cisplatin | [Cisplatin co-treated with Quercetin] results in decreased expression of BIRC5 protein | 16082193 |
| D002945 | Cisplatin | Cisplatin inhibits the reaction [Piroxicam results in increased expression of BIRC5 mRNA] | 21858171 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of BIRC5 mRNA | 11911975|1597070 |
| D002945 | Cisplatin | Cisplatin results in decreased expression of BIRC5 protein | 20674069 |
| D002945 | Cisplatin | Cisplatin results in increased expression of and results in increased phosphorylation of BIRC5 protein | 15981204 |
| D002945 | Cisplatin | Cisplatin results in increased expression of BIRC5 mRNA | 15981204|2116558 |
| D002945 | Cisplatin | Cisplatin results in increased expression of BIRC5 protein | 14988404|1739994 |
| D002945 | Cisplatin | Noscapine promotes the reaction [Cisplatin results in decreased expression of BIRC5 protein] | 20674069 |
| D002945 | Cisplatin | Proadifen inhibits the reaction [Cisplatin results in increased expression of BIRC5 protein] | 26721606 |
| D002945 | Cisplatin | tanshinone inhibits the reaction [Cisplatin results in increased expression of BIRC5 mRNA] | 21165580 |
| D002945 | Cisplatin | [TNFSF10 protein co-treated with Cisplatin] results in decreased expression of BIRC5 protein | 21252285 |
| D002945 | Cisplatin | Cisplatin results in increased expression of BIRC5 mRNA | 21151649 |
| D002945 | Cisplatin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [Cisplatin results in increased expression of BIRC5 mRNA] | 20514400 |
| D002945 | Cisplatin | Cisplatin results in increased expression of BIRC5 mRNA | 20514400 |
| C036042 | dicyclohexyl phthalate | dicyclohexyl phthalate affects the expression of BIRC5 mRNA | 26924002 |
| D004026 | Dieldrin | Dieldrin affects the expression of BIRC5 mRNA | 22546817 |
| D004041 | Dietary Fats | Dietary Fats results in increased expression of BIRC5 mRNA | 25016146 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine affects the localization of and results in increased expression of BIRC5 protein | 21776270 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of BIRC5 mRNA | 24535843 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of BIRC5 mRNA | 17854601 |
| D004052 | Diethylnitrosamine | RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of BIRC5 mRNA] | 17854601 |
| D004052 | Diethylnitrosamine | [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of BIRC5 mRNA | 18164116 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of BIRC5 mRNA | 20514400 |
| D004052 | Diethylnitrosamine | Diethylnitrosamine results in increased expression of BIRC5 protein | 20514400 |
| D004074 | Digitoxin | Digitoxin analog results in decreased expression of BIRC5 protein | 22037315 |
| D004074 | Digitoxin | Digitoxin results in decreased expression of BIRC5 protein | 22037315 |
| D002117 | Calcitriol | Calcitriol promotes the reaction [Testosterone results in increased expression of BIRC5 mRNA] | 21592394 |
| D002117 | Calcitriol | Calcitriol results in decreased expression of BIRC5 mRNA | 21592394 |
| D002117 | Calcitriol | [Testosterone co-treated with Calcitriol] results in decreased expression of BIRC5 mRNA | 21592394 |
| D002117 | Calcitriol | Testosterone promotes the reaction [Calcitriol results in increased expression of BIRC5 mRNA] | 21592394 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in increased expression of BIRC5 mRNA" | 22044346 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BIRC5 mRNA]" | 22044346 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "9,10-Dimethyl-1,2-benzanthracene results in increased expression of BIRC5 protein" | 18791811 |
| D015127 | 9,10-Dimethyl-1,2-benzanthracene | "resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BIRC5 protein]" | 18791811 |
| C067311 | docetaxel | BIRC5 protein results in decreased susceptibility to docetaxel | 16224667|1910293 |
| C067311 | docetaxel | deguelin inhibits the reaction [docetaxel results in increased expression of BIRC5 protein] | 17035597 |
| C067311 | docetaxel | docetaxel results in increased expression of BIRC5 protein | 17035597 |
| D004317 | Doxorubicin | alvocidib inhibits the reaction [Doxorubicin results in increased expression of and results in increased phosphorylation of BIRC5 protein] | 12517802 |
| D004317 | Doxorubicin | [arsenic trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BIRC5 mRNA | 24738333 |
| D004317 | Doxorubicin | [arsenic trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BIRC5 protein | 24738333 |
| D004317 | Doxorubicin | BIRC5 protein inhibits the reaction [FOXO3 protein results in increased susceptibility to Doxorubicin] | 19211844 |
| D004317 | Doxorubicin | BIRC5 protein results in decreased susceptibility to Doxorubicin | 11911975|1608687 |
| D004317 | Doxorubicin | deguelin inhibits the reaction [Doxorubicin results in increased expression of BIRC5 protein] | 17035597 |
| D004317 | Doxorubicin | Doxorubicin promotes the reaction [DNMT1 protein binds to BIRC5 promoter] | 17124180 |
| D004317 | Doxorubicin | Doxorubicin promotes the reaction [EHMT2 protein binds to BIRC5 promoter] | 17124180 |
| D004317 | Doxorubicin | Doxorubicin promotes the reaction [HDAC1 protein binds to BIRC5 promoter] | 17124180 |
| D004317 | Doxorubicin | Doxorubicin promotes the reaction [SP1 protein binds to BIRC5 promoter] | 17124180 |
| D004317 | Doxorubicin | Doxorubicin promotes the reaction [TP53 protein binds to BIRC5 promoter] | 17124180 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of BIRC5 mRNA | 11911975|1610801 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of BIRC5 promoter | 12517802 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of BIRC5 protein | 16108013|1936352 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of and results in increased phosphorylation of BIRC5 protein | 12517802 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of BIRC5 mRNA | 16086872|1752162 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of BIRC5 protein | 16086872|1703559 |
| D004317 | Doxorubicin | [FOXO3 protein results in decreased expression of BIRC5 protein] which results in increased susceptibility to Doxorubicin | 19211844 |
| D004317 | Doxorubicin | [gambogic acid co-treated with Doxorubicin] affects the expression of BIRC5 protein | 25824409 |
| D004317 | Doxorubicin | SB 203580 affects the reaction [[gambogic acid co-treated with Doxorubicin] affects the expression of BIRC5 protein] | 25824409 |
| D004317 | Doxorubicin | TP53 protein affects the reaction [Doxorubicin results in decreased expression of BIRC5 protein] | 19363521 |
| D004365 | Drugs, Chinese Herbal | "arsenic trioxide promotes the reaction [Drugs, Chinese Herbal results in decreased expression of BIRC5 protein]" | 28587418 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal promotes the reaction [arsenic trioxide results in decreased expression of BIRC5 protein]" | 28587418 |
| D004365 | Drugs, Chinese Herbal | "Drugs, Chinese Herbal results in decreased expression of BIRC5 protein" | 28587418 |
| C479799 | (E)-4-((2-N-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide | (E)-4-((2-N-(4-methoxybenzenesulfonyl)amino)stilbazole)1-oxide results in decreased expression of BIRC5 mRNA | 15528975 |
| C413879 | EKB 569 | EKB 569 results in decreased expression of BIRC5 mRNA | 22242139 |
| C413879 | EKB 569 | EKB 569 results in decreased expression of BIRC5 protein | 22242139 |
| D004642 | Emodin | Emodin results in decreased expression of BIRC5 mRNA | 23848338 |
| D004642 | Emodin | Emodin results in decreased expression of BIRC5 protein | 23848338 |
| D004726 | Endosulfan | Endosulfan results in decreased expression of BIRC5 mRNA | 26714676 |
| D015251 | Epirubicin | BIRC5 protein results in decreased susceptibility to Epirubicin | 16188142 |
| C045651 | epigallocatechin gallate | [epigallocatechin gallate co-treated with leptomycin B] results in decreased expression of BIRC5 mRNA | 25922640 |
| C045651 | epigallocatechin gallate | [epigallocatechin gallate co-treated with leptomycin B] results in decreased expression of BIRC5 protein | 25922640 |
| C078846 | epoxomicin | epoxomicin inhibits the reaction [Aspirin results in decreased expression of BIRC5 protein] | 18483385 |
| C078846 | epoxomicin | epoxomicin results in increased expression of BIRC5 protein | 17510429 |
| D000069347 | Erlotinib Hydrochloride | Erlotinib Hydrochloride promotes the reaction [resveratrol results in decreased expression of BIRC5 protein] | 25895606 |
| D000069347 | Erlotinib Hydrochloride | Erlotinib Hydrochloride results in decreased expression of BIRC5 protein | 25895606 |
| D000069347 | Erlotinib Hydrochloride | resveratrol promotes the reaction [Erlotinib Hydrochloride results in decreased expression of BIRC5 protein] | 25895606 |
| D004976 | Ethacrynic Acid | [arsenic trioxide co-treated with Ethacrynic Acid] results in decreased expression of BIRC5 protein | 23082001 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol affects the expression of BIRC5 mRNA | 17555576 |
| D004997 | Ethinyl Estradiol | Ethinyl Estradiol results in increased expression of BIRC5 mRNA | 17942748 |
| D004997 | Ethinyl Estradiol | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BIRC5 mRNA | 17942748 |
| D017308 | Etodolac | Etodolac results in decreased expression of BIRC5 protein | 16004971|1610487 |
| D017308 | Etodolac | Etodolac results in increased activity of BIRC5 protein | 16046235 |
| D017308 | Etodolac | [oxaliplatin co-treated with Etodolac] results in decreased expression of BIRC5 protein | 16004971 |
| D005047 | Etoposide | BIRC5 protein inhibits the reaction [FOXO3 protein results in increased susceptibility to Etoposide] | 19211844 |
| D005047 | Etoposide | BIRC5 protein results in decreased susceptibility to [Cisplatin co-treated with Etoposide] | 15917659|1638289 |
| D005047 | Etoposide | BIRC5 protein results in decreased susceptibility to Etoposide | 16322251|1636492 |
| D005047 | Etoposide | Estradiol inhibits the reaction [Etoposide results in increased expression of BIRC5 mRNA] | 19426747 |
| D005047 | Etoposide | Etoposide results in increased expression of BIRC5 mRNA | 19426747 |
| D005047 | Etoposide | [FOXO3 protein results in decreased expression of BIRC5 protein] which results in increased susceptibility to Etoposide | 19211844 |
| D000068338 | Everolimus | Everolimus promotes the reaction [platycodin D results in decreased expression of BIRC5 protein] | 28711525 |
| D000068338 | Everolimus | Everolimus results in decreased expression of BIRC5 protein | 21601561|2871152 |
| D000068338 | Everolimus | navitoclax promotes the reaction [Everolimus results in decreased expression of BIRC5 protein] | 28947240 |
| D000068338 | Everolimus | platycodin D promotes the reaction [Everolimus results in decreased expression of BIRC5 protein] | 28711525 |
| C049639 | evodiamine | evodiamine inhibits the reaction [TNF protein results in increased expression of BIRC5 protein] | 15710601 |
| D015025 | Zearalenone | Zearalenone results in increased expression of BIRC5 mRNA | 28965971 |
| C060802 | fangchinoline | fangchinoline results in decreased expression of BIRC5 mRNA | 28754437 |
| C060802 | fangchinoline | fangchinoline results in decreased expression of BIRC5 protein | 28754437 |
| C004808 | farnesyl pyrophosphate | farnesyl pyrophosphate inhibits the reaction [Lovastatin results in decreased expression of BIRC5 protein] | 17472962 |
| C093323 | farnesylthiosalicylic acid | farnesylthiosalicylic acid results in decreased expression of BIRC5 protein | 16780807 |
| C017875 | fisetin | [Cisplatin co-treated with fisetin] results in decreased expression of BIRC5 protein | 21216935 |
| C548902 | FLLL 32 | FLLL 32 results in decreased expression of BIRC5 mRNA | 21109950 |
| C548902 | FLLL 32 | FLLL 32 results in decreased expression of BIRC5 protein | 20576164|2110995 |
| D015073 | 2-Acetylaminofluorene | 2-Acetylaminofluorene results in increased expression of BIRC5 mRNA | 19167416|2221319 |
| D005459 | Fluorides | [Arsenic co-treated with Fluorides] results in increased expression of BIRC5 mRNA | 19962721 |
| D005459 | Fluorides | Fluorides results in increased expression of BIRC5 mRNA | 19962721 |
| D005472 | Fluorouracil | BIRC5 affects the susceptibility to Fluorouracil | 15067352 |
| D005472 | Fluorouracil | BIRC5 protein affects the susceptibility to Fluorouracil | 16217747|1871415 |
| D005472 | Fluorouracil | BIRC5 protein results in decreased susceptibility to Fluorouracil | 15685548 |
| D005472 | Fluorouracil | BIRC5 results in decreased susceptibility to Fluorouracil | 16546719|1961860 |
| D005472 | Fluorouracil | [Fluorouracil co-treated with RNF34 protein] results in increased expression of BIRC5 protein | 16596200 |
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of BIRC5 mRNA | 16709241|1692916 |
| D005472 | Fluorouracil | Fluorouracil results in decreased expression of BIRC5 protein | 16929163|1739994 |
| D005472 | Fluorouracil | Fluorouracil results in increased expression of BIRC5 mRNA | 15109396|2859947 |
| D005472 | Fluorouracil | Fluorouracil results in increased expression of BIRC5 protein | 17399942 |
| D005472 | Fluorouracil | gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BIRC5 mRNA] | 16929163 |
| D005472 | Fluorouracil | gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BIRC5 protein] | 16929163 |
| D005472 | Fluorouracil | [SM-1 compound co-treated with Fluorouracil] results in decreased expression of BIRC5 mRNA | 28599477 |
| D005472 | Fluorouracil | SM-1 compound inhibits the reaction [Fluorouracil results in increased expression of BIRC5 mRNA] | 28599477 |
| D005472 | Fluorouracil | SM-1 compound promotes the reaction [Fluorouracil results in decreased expression of BIRC5 protein] | 28599477 |
| D005480 | Flurbiprofen | Flurbiprofen results in increased expression of BIRC5 mRNA | 16949054 |
| C007789 | fucoidan | fucoidan results in decreased expression of BIRC5 protein | 16201850 |
| C070081 | fulvestrant | [fulvestrant co-treated with Sirolimus] results in decreased expression of BIRC5 mRNA | 19016759 |
| C070081 | fulvestrant | fulvestrant results in decreased expression of BIRC5 mRNA | 19016759 |
| C070081 | fulvestrant | fulvestrant results in decreased expression of BIRC5 mRNA | 21980073 |
| C039281 | furan | [Bromodeoxyuridine co-treated with furan] results in increased expression of BIRC5 mRNA | 24910943 |
| C039281 | furan | furan results in increased expression of BIRC5 mRNA | 24183702|2491094 |
| C039281 | furan | furan results in increased expression of BIRC5 mRNA | 22079235|2553966 |
| D005665 | Furosemide | Furosemide affects the expression of BIRC5 mRNA | 17497460 |
| C052659 | gambogic acid | gambogic acid affects the expression of BIRC5 protein | 25824409 |
| C052659 | gambogic acid | [gambogic acid co-treated with Doxorubicin] affects the expression of BIRC5 protein | 25824409 |
| C052659 | gambogic acid | SB 203580 affects the reaction [[gambogic acid co-treated with Doxorubicin] affects the expression of BIRC5 protein] | 25824409 |
| C106014 | gedunin | gedunin results in decreased expression of BIRC5 mRNA | 17010675 |
| C419708 | gefitinib | gefitinib results in decreased expression of BIRC5 protein | 28942004 |
| C419708 | gefitinib | gefitinib results in increased expression of BIRC5 protein | 17473213 |
| C419708 | gefitinib | leptomycin B promotes the reaction [gefitinib results in decreased expression of BIRC5 protein] | 28942004 |
| C419708 | gefitinib | tyrphostin AG 1024 inhibits the reaction [gefitinib results in increased expression of BIRC5 protein] | 17473213 |
| C056507 | gemcitabine | gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BIRC5 mRNA] | 16929163 |
| C056507 | gemcitabine | gemcitabine inhibits the reaction [Fluorouracil results in decreased expression of BIRC5 protein] | 16929163 |
| C056507 | gemcitabine | [Curcumin co-treated with gemcitabine] results in decreased expression of BIRC5 protein | 17440100 |
| D019833 | Genistein | Genistein inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein] | 23452621 |
| D019833 | Genistein | Genistein results in decreased expression of BIRC5 mRNA | 16705744 |
| D019833 | Genistein | Genistein results in increased expression of BIRC5 mRNA | 16474171 |
| C002963 | geranylgeranyl pyrophosphate | geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in decreased expression of BIRC5 protein] | 17472962 |
| C007845 | gingerol | Acetylcysteine inhibits the reaction [gingerol results in decreased expression of BIRC5 protein] | 25034532 |
| C007845 | gingerol | gingerol inhibits the reaction [Testosterone results in increased expression of BIRC5 protein] | 18030663 |
| C007845 | gingerol | gingerol results in decreased expression of BIRC5 protein | 18030663|2503453 |
| C007845 | gingerol | gingerol inhibits the reaction [Testosterone results in increased expression of BIRC5 protein] | 18030663 |
| C097367 | ginsenoside Rg3 | ginsenoside Rg3 results in decreased expression of BIRC5 mRNA | 19778801 |
| C097367 | ginsenoside Rg3 | ginsenoside Rg3 results in decreased expression of BIRC5 protein | 19778801 |
| C086854 | glycine-extended gastrin 17 | glycine-extended gastrin 17 results in increased expression of BIRC5 mRNA | 19153190 |
| C086854 | glycine-extended gastrin 17 | glycine-extended gastrin 17 results in increased expression of BIRC5 protein | 19153190 |
| C086854 | glycine-extended gastrin 17 | STAT3 protein affects the reaction [glycine-extended gastrin 17 results in increased expression of BIRC5 protein] | 19153190 |
| C086854 | glycine-extended gastrin 17 | stattic inhibits the reaction [glycine-extended gastrin 17 results in increased expression of BIRC5 mRNA] | 19153190 |
| D005999 | Glycochenodeoxycholic Acid | Glycochenodeoxycholic Acid results in increased expression of BIRC5 mRNA | 15767249 |
| C568713 | GSK1210151A | GSK1210151A results in decreased expression of BIRC5 mRNA | 26877780 |
| C568713 | GSK1210151A | GSK1210151A results in decreased expression of BIRC5 protein | 26877780 |
| D018738 | Hexamethonium | Hexamethonium affects the reaction [Nicotine results in increased expression of BIRC5 protein] | 16601104 |
| D017313 | Fenretinide | Fenretinide results in increased expression of BIRC5 mRNA | 28973697 |
| D006861 | Hydrogen Peroxide | Hydrogen Peroxide affects the expression of BIRC5 mRNA | 20044591|2651922 |
| D006877 | Hydroxamic Acids | Hydroxamic Acids analog results in decreased expression of BIRC5 protein | 26088127 |
| C021304 | hyperoside | [Quercetin co-treated with hyperoside] results in decreased expression of BIRC5 mRNA | 24173369 |
| C021304 | hyperoside | [Quercetin co-treated with hyperoside] results in decreased expression of BIRC5 protein | 24173369 |
| D000068877 | Imatinib Mesylate | BIRC5 protein results in decreased susceptibility to Imatinib Mesylate | 16166298|1625414 |
| D000068877 | Imatinib Mesylate | Imatinib Mesylate results in decreased expression of BIRC5 protein | 16254145 |
| C016517 | indole-3-carbinol | indole-3-carbinol inhibits the reaction [TNF protein results in increased expression of BIRC5 protein] | 15811958 |
| C016517 | indole-3-carbinol | indole-3-carbinol results in decreased expression of BIRC5 | 16082211 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of BIRC5 mRNA | 15248904|1727014 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of BIRC5 protein | 17270149 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of BIRC5 mRNA | 28628672 |
| D007213 | Indomethacin | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BIRC5 mRNA | 28628672 |
| D007213 | Indomethacin | butaprost inhibits the reaction [[Indomethacin results in decreased activity of PTGS2 protein] which results in decreased expression of BIRC5 protein] | 21268125 |
| D007213 | Indomethacin | Dinoprostone inhibits the reaction [[Indomethacin results in decreased activity of PTGS2 protein] which results in decreased expression of BIRC5 protein] | 21268125 |
| D007213 | Indomethacin | [Indomethacin results in decreased activity of PTGS2 protein] which results in decreased expression of BIRC5 protein | 21268125 |
| D007213 | Indomethacin | Indomethacin results in decreased expression of BIRC5 protein | 17654042 |
| D007213 | Indomethacin | TXN protein inhibits the reaction [Indomethacin results in decreased expression of BIRC5 protein] | 17654042 |
| C051890 | irinotecan | [irinotecan co-treated with Bortezomib] results in decreased expression of BIRC5 protein | 16373703 |
| C051890 | irinotecan | irinotecan metabolite results in decreased expression of BIRC5 mRNA | 15956246 |
| C051890 | irinotecan | irinotecan promotes the reaction [AS602868 results in decreased expression of BIRC5 mRNA] | 18182997 |
| C051890 | irinotecan | irinotecan results in decreased expression of BIRC5 mRNA | 15956246 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bis(4-hydroxyphenyl)sulfone] results in decreased expression of BIRC5 mRNA | 28628672 |
| D015056 | 1-Methyl-3-isobutylxanthine | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of BIRC5 mRNA | 28628672 |
| D007530 | Isoflurane | Isoflurane results in decreased expression of BIRC5 mRNA | 16978161 |
| C055785 | jatrorrhizine | jatrorrhizine binds to BIRC5 promoter | 17968851 |
| C544151 | jinfukang | [Cisplatin co-treated with jinfukang] results in decreased expression of BIRC5 mRNA | 27392435 |
| C544151 | jinfukang | jinfukang results in increased expression of BIRC5 mRNA | 27392435 |
| C561695 | (+)-JQ1 compound | Anisomycin promotes the reaction [(+)-JQ1 compound results in decreased expression of BIRC5 protein] | 23872705 |
| C561695 | (+)-JQ1 compound | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [(+)-JQ1 compound results in decreased expression of BIRC5 protein] | 23872705 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound affects the expression of BIRC5 mRNA | 26397223 |
| C561695 | (+)-JQ1 compound | [(+)-JQ1 compound co-treated with vemurafenib] results in decreased expression of BIRC5 mRNA | 27169980 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of BIRC5 mRNA | 23430699|2596192 |
| C561695 | (+)-JQ1 compound | (+)-JQ1 compound results in decreased expression of BIRC5 protein | 23872705|2687778 |
| C410337 | K 7174 | K 7174 results in decreased expression of BIRC5 mRNA | 24086573 |
| C510621 | KCC 009 | KCC 009 results in decreased expression of BIRC5 protein | 16170020 |
| C572783 | kuguacin J | kuguacin J results in decreased expression of BIRC5 protein | 22266361 |
| C490728 | lapatinib | lapatinib results in decreased expression of BIRC5 protein | 16091755 |
| D007840 | Latex | Latex analog results in increased expression of BIRC5 mRNA | 24768652 |
| C045463 | leflunomide | leflunomide results in decreased expression of BIRC5 mRNA | 28988120 |
| C038753 | leptomycin B | [epigallocatechin gallate co-treated with leptomycin B] results in decreased expression of BIRC5 mRNA | 25922640 |
| C038753 | leptomycin B | [epigallocatechin gallate co-treated with leptomycin B] results in decreased expression of BIRC5 protein | 25922640 |
| C038753 | leptomycin B | [leptomycin B co-treated with TP53 gene mutant form] results in increased expression of BIRC5 mRNA | 20803015 |
| C038753 | leptomycin B | leptomycin B promotes the reaction [gefitinib results in decreased expression of BIRC5 protein] | 28942004 |
| C038753 | leptomycin B | leptomycin B results in decreased expression of BIRC5 mRNA | 20803015|2592264 |
| C038753 | leptomycin B | leptomycin B results in decreased expression of BIRC5 protein | 20803015|2592264 |
| C038753 | leptomycin B | TP53 gene mutant form inhibits the reaction [leptomycin B results in decreased expression of BIRC5 protein] | 20803015 |
| C541528 | licochalcone B | licochalcone B results in decreased expression of BIRC5 protein | 24384411 |
| D008094 | Lithium | Lithium results in increased expression of BIRC5 mRNA | 16288908 |
| D018021 | Lithium Chloride | Lithium Chloride inhibits the reaction [manganese chloride results in decreased expression of BIRC5 mRNA] | 24464479 |
| C549232 | LLL12 compound | LLL12 compound results in decreased expression of BIRC5 mRNA | 21109950 |
| C549232 | LLL12 compound | LLL12 compound results in decreased expression of BIRC5 protein | 21109950 |
| C115354 | lonafarnib | lonafarnib inhibits the reaction [TNF protein results in increased expression of BIRC5 protein] | 15090542 |
| D008148 | Lovastatin | farnesyl pyrophosphate inhibits the reaction [Lovastatin results in decreased expression of BIRC5 protein] | 17472962 |
| D008148 | Lovastatin | geranylgeranyl pyrophosphate inhibits the reaction [Lovastatin results in decreased expression of BIRC5 protein] | 17472962 |
| D008148 | Lovastatin | Lovastatin results in decreased expression of BIRC5 protein | 17472962|1881588 |
| D008154 | Lucanthone | Lucanthone results in decreased expression of BIRC5 mRNA | 21148553 |
| D008277 | Magnesium Oxide | Magnesium Oxide analog inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA] | 27920530 |
| D008277 | Magnesium Oxide | [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA] | 27920530 |
| D058185 | Magnetite Nanoparticles | [arsenic trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BIRC5 mRNA | 24738333 |
| D058185 | Magnetite Nanoparticles | [arsenic trioxide co-treated with Doxorubicin co-treated with Magnetite Nanoparticles analog] affects the expression of BIRC5 protein | 24738333 |
| D058185 | Magnetite Nanoparticles | [Daunorubicin co-treated with bromotetrandrine co-treated with Magnetite Nanoparticles] results in decreased expression of BIRC5 mRNA | 21720514 |
| D058185 | Magnetite Nanoparticles | [Daunorubicin co-treated with bromotetrandrine co-treated with Magnetite Nanoparticles] results in decreased expression of BIRC5 protein | 21720514 |
| C025340 | manganese chloride | Lithium Chloride inhibits the reaction [manganese chloride results in decreased expression of BIRC5 mRNA] | 24464479 |
| C025340 | manganese chloride | manganese chloride results in decreased expression of BIRC5 mRNA | 24464479 |
| C013592 | mangiferin | mangiferin results in decreased expression of BIRC5 protein | 26996543 |
| C034244 | matrine | arsenic trioxide promotes the reaction [matrine results in decreased expression of BIRC5 protein] | 23700110 |
| C034244 | matrine | matrine promotes the reaction [arsenic trioxide results in decreased expression of BIRC5 protein] | 23700110 |
| C034244 | matrine | matrine results in decreased expression of BIRC5 protein | 23700110 |
| C540278 | MDV 3100 | MDV 3100 promotes the reaction [Niclosamide results in decreased expression of BIRC5 protein] | 25970160 |
| D008558 | Melphalan | BIRC5 protein affects the susceptibility to Melphalan | 16373717 |
| D008558 | Melphalan | Nocodazole affects the reaction [BIRC5 protein affects the susceptibility to Melphalan] | 16373717 |
| D008558 | Melphalan | Paclitaxel affects the reaction [BIRC5 protein affects the susceptibility to Melphalan] | 16373717 |
| D008694 | Methamphetamine | Methamphetamine results in decreased expression of BIRC5 mRNA | 25290377 |
| D008713 | Methimazole | Methimazole results in decreased expression of BIRC5 mRNA | 17403546 |
| D008730 | Methoxsalen | BHLHE40 protein inhibits the reaction [Methoxsalen results in decreased expression of BIRC5 protein] | 22796345 |
| D008730 | Methoxsalen | Methoxsalen results in decreased expression of BIRC5 protein | 22796345 |
| C005219 | methyl cellosolve | methyl cellosolve results in decreased expression of BIRC5 mRNA | 19643169 |
| D008748 | Methylcholanthrene | Methylcholanthrene results in increased expression of BIRC5 mRNA | 20713471 |
| C004925 | methylmercuric chloride | methylmercuric chloride results in decreased expression of BIRC5 mRNA | 19465457 |
| C030589 | methylmercury cysteine | methylmercury cysteine results in decreased expression of BIRC5 mRNA | 19465457 |
| D008770 | Methylnitrosourea | Methylnitrosourea results in increased expression of BIRC5 mRNA | 25270620 |
| D015655 | 1-Methyl-4-phenylpyridinium | 1-Methyl-4-phenylpyridinium results in decreased expression of BIRC5 mRNA | 24810058 |
| C008493 | methylselenic acid | "[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in decreased expression of BIRC5 protein" | 18444175 |
| C008493 | methylselenic acid | methylselenic acid inhibits the reaction [SP1 protein binds to BIRC5 promoter] | 17876054 |
| C008493 | methylselenic acid | methylselenic acid results in decreased expression of BIRC5 mRNA | 12517777|1787605 |
| C008493 | methylselenic acid | methylselenic acid results in decreased expression of BIRC5 protein | 17876054|1844417 |
| D008777 | Methyltestosterone | Methyltestosterone results in decreased expression of BIRC5 mRNA | 29191790 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Dexamethasone results in increased expression of BIRC5] | 21244764 |
| C066851 | mithramycin A | mithramycin A results in decreased expression of BIRC5 mRNA | 17124180 |
| D016685 | Mitomycin | Mitomycin results in increased expression of BIRC5 mRNA | 18250050 |
| D016685 | Mitomycin | Mitomycin results in increased expression of BIRC5 protein | 18250050 |
| D008942 | Mitoxantrone | Mitoxantrone affects the expression of BIRC5 mRNA | 16638212 |
| D008942 | Mitoxantrone | Mitoxantrone results in increased expression of BIRC5 protein | 16638212 |
| C070571 | ML 7 | ML 7 results in decreased expression of BIRC5 protein | 18710790 |
| D016686 | Monocrotaline | Monocrotaline results in increased expression of BIRC5 mRNA | 25460361 |
| D016686 | Monocrotaline | Quercetin inhibits the reaction [Monocrotaline results in increased expression of BIRC5 mRNA] | 25460361 |
| C008542 | monodansylcadaverine | monodansylcadaverine results in decreased expression of BIRC5 protein | 16170020 |
| C517284 | monomethyl phthalate | monomethyl phthalate affects the expression of BIRC5 mRNA | 26924002 |
| C008548 | morin | morin results in decreased expression of BIRC5 mRNA | 28689916 |
| C437683 | motexafin gadolinium | motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of BIRC5 mRNA] | 16357179 |
| C437683 | motexafin gadolinium | motexafin gadolinium results in increased expression of BIRC5 mRNA | 16357179 |
| D009151 | Mustard Gas | Mustard Gas results in decreased expression of BIRC5 mRNA | 25102026 |
| C455139 | myrtucommulone A | myrtucommulone A results in decreased expression of BIRC5 mRNA | 26032814 |
| C583365 | N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide | "N-(2-(1,1'-bicyclopropyl)-2-ylphenyl)-3-(difluoromethyl)-1-methyl-1H-pyrazole-4-carboxamide results in increased expression of BIRC5 mRNA" | 29244179 |
| C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Quercetin results in decreased expression of BIRC5 protein] | 18377872 |
| C550356 | N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide | "(5-(2,4-bis((3S)-3-methylmorpholin-4-yl)pyrido(2,3-d)pyrimidin-7-yl)-2-methoxyphenyl)methanol inhibits the reaction [N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide results in increased expression of and affects the localization of BIRC5 protein]" | 24444656 |
| C550356 | N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide | "N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide results in increased expression of and affects the localization of BIRC5 protein" | 24444656 |
| C550356 | N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide | "[N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide results in increased expression of BIRC5 protein] which affects the susceptibility to YM 155" | 24444656 |
| C550356 | N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide | "Sirolimus inhibits the reaction [N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide results in increased expression of and affects the localization of BIRC5 protein]" | 24444656 |
| C084956 | N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine | BIRC5 protein results in decreased susceptibility to N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine | 16088125 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon affects the expression of BIRC5 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon analog affects the expression of BIRC5 mRNA" | 25554681 |
| D037742 | Nanotubes, Carbon | "Nanotubes, Carbon results in decreased expression of BIRC5 mRNA" | 25620056 |
| C000621033 | napabucasin | napabucasin results in decreased expression of BIRC5 mRNA | 26899963 |
| C000621033 | napabucasin | napabucasin results in decreased expression of BIRC5 protein | 25605917|2689996 |
| C031721 | naphthalene | naphthalene results in increased expression of BIRC5 mRNA | 18978301 |
| C073873 | naphtho(1,2-b)furan-4,5-dione | "2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [naphtho(1,2-b)furan-4,5-dione results in decreased expression of BIRC5 protein]" | 19747539 |
| C073873 | naphtho(1,2-b)furan-4,5-dione | "naphtho(1,2-b)furan-4,5-dione results in decreased expression of BIRC5 protein" | 19747539|2019708 |
| C073873 | naphtho(1,2-b)furan-4,5-dione | "pyrazolanthrone inhibits the reaction [naphtho(1,2-b)furan-4,5-dione results in decreased expression of BIRC5 protein]" | 19747539 |
| C528561 | navitoclax | [MTOR protein affects the susceptibility to navitoclax] which affects the expression of BIRC5 protein | 28947240 |
| C528561 | navitoclax | navitoclax promotes the reaction [Everolimus results in decreased expression of BIRC5 protein] | 28947240 |
| C528561 | navitoclax | navitoclax results in decreased expression of BIRC5 protein | 28947240 |
| D009532 | Nickel | Nickel results in increased expression of BIRC5 mRNA | 19031421|2558310 |
| D009532 | Nickel | [Quercetin analog co-treated with Nickel] results in decreased expression of BIRC5 protein | 20577783 |
| C022838 | nickel chloride | nickel chloride affects the expression of BIRC5 mRNA | 22546817 |
| C550717 | nickel ferrite | nickel ferrite results in decreased expression of BIRC5 mRNA | 21382431 |
| C029938 | nickel sulfate | nickel sulfate affects the localization of and results in increased expression of BIRC5 protein | 21776270 |
| D009534 | Niclosamide | MDV 3100 promotes the reaction [Niclosamide results in decreased expression of BIRC5 protein] | 25970160 |
| D009534 | Niclosamide | Niclosamide affects the expression of BIRC5 protein | 24552774 |
| D009534 | Niclosamide | Niclosamide inhibits the reaction [IL6 protein results in increased expression of BIRC5 protein] | 25970160 |
| D009534 | Niclosamide | Niclosamide results in decreased expression of BIRC5 protein | 24736023|2597016 |
| D009538 | Nicotine | Curcumin inhibits the reaction [Nicotine results in increased expression of BIRC5 protein] | 20727180 |
| D009538 | Nicotine | Hexamethonium affects the reaction [Nicotine results in increased expression of BIRC5 protein] | 16601104 |
| D009538 | Nicotine | Nicotine inhibits the reaction [RB1 protein binds to BIRC5 promoter] | 16601104 |
| D009538 | Nicotine | Nicotine promotes the reaction [E2F1 protein binds to BIRC5 promoter] | 16601104 |
| D009538 | Nicotine | Nicotine results in increased expression of BIRC5 mRNA | 16601104|1989649 |
| D009538 | Nicotine | Nicotine results in increased expression of BIRC5 protein | 16601104|2072718 |
| C042198 | nimbolide | nimbolide results in decreased expression of BIRC5 protein | 20429769 |
| C012655 | nimesulide | nimesulide results in decreased expression of BIRC5 protein | 16969492 |
| D009569 | Nitric Oxide | Nitric Oxide results in decreased expression of BIRC5 mRNA | 15126337 |
| D009569 | Nitric Oxide | Nitric Oxide results in decreased expression of BIRC5 protein | 16166326 |
| D009599 | Nitroprusside | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [Nitroprusside results in decreased expression of BIRC5 protein] | 14988404 |
| D009599 | Nitroprusside | 6-((3-chloro)anilino)-2-(isopropyl-2-hydroxyethylamino)-9-isopropylpurine promotes the reaction [Nitroprusside results in decreased expression of BIRC5 mRNA] | 14988404 |
| D009599 | Nitroprusside | Nitroprusside results in decreased expression of BIRC5 mRNA | 14988404 |
| D009599 | Nitroprusside | Nitroprusside results in decreased expression of BIRC5 protein | 14988404 |
| D009599 | Nitroprusside | NSC 663284 promotes the reaction [Nitroprusside results in decreased expression of BIRC5 mRNA] | 14988404 |
| C047330 | N-methylisoindigotin | N-methylisoindigotin results in decreased expression of BIRC5 protein | 26887594 |
| D015739 | Nocodazole | Nocodazole affects the reaction [BIRC5 protein affects the susceptibility to Melphalan] | 16373717 |
| D009665 | Noscapine | BIRC5 protein results in decreased susceptibility to Noscapine | 22848370 |
| D009665 | Noscapine | Noscapine promotes the reaction [Cisplatin results in decreased expression of BIRC5 protein] | 20674069 |
| D009665 | Noscapine | Noscapine results in decreased expression of BIRC5 protein | 20674069 |
| D009665 | Noscapine | Noscapine results in increased expression of BIRC5 mRNA | 22848370 |
| D009665 | Noscapine | Noscapine results in increased expression of BIRC5 protein | 22848370 |
| C440614 | NSC 663284 | NSC 663284 promotes the reaction [Nitroprusside results in decreased expression of BIRC5 mRNA] | 14988404 |
| C558013 | NSC 689534 | [NSC 689534 binds to Copper] which results in decreased expression of BIRC5 mRNA | 20971185 |
| C025589 | ochratoxin A | ochratoxin A results in decreased expression of BIRC5 mRNA | 27193732 |
| C025589 | ochratoxin A | ochratoxin A results in increased expression of BIRC5 mRNA | 19237604|1956249 |
| C025589 | ochratoxin A | ochratoxin A results in increased expression of BIRC5 protein | 19237604 |
| C016340 | o,p'-DDT | "o,p'-DDT analog results in decreased expression of BIRC5 mRNA" | 22937105 |
| C030110 | oxaliplatin | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [oxaliplatin results in decreased expression of BIRC5 protein] | 20708607 |
| C030110 | oxaliplatin | benzyloxycarbonylleucyl-leucyl-leucine aldehyde results in decreased susceptibility to [oxaliplatin results in decreased expression of BIRC5 protein] | 20708607 |
| C030110 | oxaliplatin | BIRC5 protein results in decreased susceptibility to oxaliplatin | 20708607 |
| C030110 | oxaliplatin | [oxaliplatin co-treated with Etodolac] results in decreased expression of BIRC5 protein | 16004971 |
| C030110 | oxaliplatin | oxaliplatin results in decreased expression of BIRC5 mRNA | 20708607 |
| C030110 | oxaliplatin | oxaliplatin results in decreased expression of BIRC5 protein | 16004971|1602453 |
| C030110 | oxaliplatin | oxaliplatin results in increased expression of BIRC5 protein | 19147571 |
| C030110 | oxaliplatin | [oxaliplatin co-treated with Topotecan] results in decreased expression of BIRC5 mRNA | 25729387 |
| C030110 | oxaliplatin | oxaliplatin results in decreased expression of BIRC5 mRNA | 25729387 |
| C030110 | oxaliplatin | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole affects the reaction [BIRC5 protein results in decreased susceptibility to oxaliplatin] | 20708607 |
| C552952 | oxazolinodaunorubicin | oxazolinodaunorubicin affects the expression of BIRC5 mRNA | 27780733 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of BIRC5 mRNA | 22711276 |
| D010100 | Oxygen | Valproic Acid inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 mRNA] | 22711276 |
| D010100 | Oxygen | vorinostat inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 mRNA] | 22711276 |
| D010100 | Oxygen | "3,5-bis(2-fluorobenzylidene)piperidin-4-one inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein]" | 23452621 |
| D010100 | Oxygen | [arsenic trioxide co-treated with Oxygen deficiency] results in decreased expression of BIRC5 mRNA | 19825857 |
| D010100 | Oxygen | [arsenic trioxide co-treated with Oxygen deficiency] results in decreased expression of BIRC5 protein | 19825857 |
| D010100 | Oxygen | betulin analog promotes the reaction [Oxygen deficiency results in decreased expression of BIRC5 protein] | 26540049 |
| D010100 | Oxygen | betulinic acid promotes the reaction [Oxygen deficiency results in decreased expression of BIRC5 protein] | 26540049 |
| D010100 | Oxygen | Curcumin inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein] | 23452621 |
| D010100 | Oxygen | Genistein inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein] | 23452621 |
| D010100 | Oxygen | HIF1A affects the reaction [Oxygen deficiency affects the expression of BIRC5 mRNA] | 16628086 |
| D010100 | Oxygen | HIF1A affects the reaction [Oxygen deficiency affects the expression of BIRC5 protein] | 16628086 |
| D010100 | Oxygen | ITGB1 affects the reaction [Oxygen deficiency affects the expression of BIRC5 mRNA] | 16628086 |
| D010100 | Oxygen | ITGB1 affects the reaction [Oxygen deficiency affects the expression of BIRC5 protein] | 16628086 |
| D010100 | Oxygen | Oxygen deficiency results in decreased expression of BIRC5 protein | 26540049 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of BIRC5 mRNA | 23452621 |
| D010100 | Oxygen | Oxygen deficiency results in increased expression of BIRC5 protein | 23452621 |
| D010100 | Oxygen | Oxygen results in decreased expression of BIRC5 mRNA | 27103661 |
| D010100 | Oxygen | Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein] | 23452621 |
| D010100 | Oxygen | resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein] | 23452621 |
| D010126 | Ozone | Ozone results in increased expression of BIRC5 mRNA | 12763052|1955522 |
| D010126 | Ozone | TTPA protein affects the reaction [Ozone results in increased expression of BIRC5 mRNA] | 19555225 |
| D017239 | Paclitaxel | "4-((3-bromophenyl)amino)-6,7-dimethoxyquinazoline inhibits the reaction [Paclitaxel results in increased expression of BIRC5]" | 16211241 |
| D017239 | Paclitaxel | "[4-(6-cyclohexylmethoxy-9H-purin-2-ylamino)-N,N-diethylbenzamide co-treated with Paclitaxel] results in decreased expression of BIRC5 protein" | 16170024 |
| D017239 | Paclitaxel | BIRC5 protein results in decreased susceptibility to Paclitaxel | 16202317 |
| D017239 | Paclitaxel | BIRC5 results in decreased susceptibility to Paclitaxel | 19133282 |
| D017239 | Paclitaxel | Paclitaxel affects the reaction [BIRC5 protein affects the susceptibility to Melphalan] | 16373717 |
| D017239 | Paclitaxel | Paclitaxel results in decreased expression of BIRC5 mRNA | 15970709 |
| D017239 | Paclitaxel | Paclitaxel results in decreased expression of BIRC5 promoter | 12517802 |
| D017239 | Paclitaxel | Paclitaxel results in decreased expression of BIRC5 protein | 14749477|1739994 |
| D017239 | Paclitaxel | Paclitaxel results in increased expression of BIRC5 | 16211241 |
| D017239 | Paclitaxel | Paclitaxel results in increased expression of BIRC5 protein | 12517802|1739994 |
| D017239 | Paclitaxel | Prodigiosin inhibits the reaction [Paclitaxel results in increased expression of BIRC5 protein] | 19133282 |
| D017239 | Paclitaxel | [Tretinoin co-treated with Paclitaxel] results in decreased expression of BIRC5 protein | 17701358|1809827 |
| D017239 | Paclitaxel | vorinostat inhibits the reaction [Paclitaxel results in increased expression of BIRC5 protein] | 19875160 |
| C500026 | palbociclib | palbociclib results in decreased expression of BIRC5 mRNA | 22869556 |
| C005413 | palmatine | palmatine binds to BIRC5 promoter | 17968851 |
| D010269 | Paraquat | Paraquat results in increased expression of BIRC5 mRNA | 26345256 |
| D010269 | Paraquat | Paraquat results in decreased expression of BIRC5 mRNA | 26887261 |
| D052638 | Particulate Matter | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Particulate Matter results in decreased expression of BIRC5 mRNA] | 28655636 |
| D052638 | Particulate Matter | Particulate Matter results in decreased expression of BIRC5 mRNA | 28655636 |
| C418868 | PBOX-6 | [alvocidib co-treated with PBOX-6] results in decreased expression of BIRC5 protein | 20206141 |
| C418868 | PBOX-6 | BIRC5 results in decreased susceptibility to PBOX-6 | 20206141 |
| C000610380 | p-carboxymethylphenyl 1,1-bis(3'-indolyl)-1-(p-carboxymethylphenyl)methane | "p-carboxymethylphenyl 1,1-bis(3'-indolyl)-1-(p-carboxymethylphenyl)methane results in decreased expression of BIRC5 protein" | 26035713 |
| C410127 | PCB 180 | "[2,4,4'-trichlorobiphenyl co-treated with 2,5,2',5'-tetrachlorobiphenyl co-treated with 2,4,5,2',5'-pentachlorobiphenyl co-treated with 2,2',3',4,4',5-hexachlorobiphenyl co-treated with 2,4,5,2',4',5'-hexachlorobiphenyl co-treated with PCB 180] results in increased expression of BIRC5 mRNA" | 25510870 |
| C115711 | PD 173074 | [arsenic trioxide results in increased susceptibility to PD 173074] which results in decreased expression of BIRC5 protein | 27794399 |
| C086401 | pentabromodiphenyl ether | pentabromodiphenyl ether results in decreased expression of BIRC5 mRNA | 23948077 |
| C494474 | perchlorate | perchlorate results in decreased expression of BIRC5 mRNA | 17403546 |
| C076994 | perfluorooctane sulfonic acid | perfluorooctane sulfonic acid affects the expression of BIRC5 mRNA | 27018151 |
| C023036 | perfluorooctanoic acid | NR1H3 protein affects the reaction [perfluorooctanoic acid results in increased expression of BIRC5 mRNA] | 25949234 |
| C023036 | perfluorooctanoic acid | perfluorooctanoic acid results in increased expression of BIRC5 mRNA | 25949234 |
| D015232 | Dinoprostone | Dinoprostone inhibits the reaction [[Indomethacin results in decreased activity of PTGS2 protein] which results in decreased expression of BIRC5 protein] | 21268125 |
| D010634 | Phenobarbital | [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of BIRC5 mRNA | 24535843 |
| D010634 | Phenobarbital | Phenobarbital results in increased expression of BIRC5 mRNA | 19363144|2040396 |
| D010662 | Phenylmercuric Acetate | "[NOG protein co-treated with Phenylmercuric Acetate co-treated with (6-(4-(2-piperidin-1-ylethoxy)phenyl))-3-pyridin-4-ylpyrazolo(1,5-a)pyrimidine co-treated with 4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of BIRC5 mRNA" | 27188386 |
| D010662 | Phenylmercuric Acetate | Phenylmercuric Acetate results in decreased expression of BIRC5 mRNA | 26272509 |
| D048789 | Phytoestrogens | Phytoestrogens results in increased expression of BIRC5 mRNA | 18310284 |
| C415032 | picropodophyllin | picropodophyllin results in decreased expression of BIRC5 protein | 16166596 |
| C121565 | pifithrin | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[pifithrin co-treated with Topotecan] results in increased degradation of BIRC5 protein] | 19812371 |
| C121565 | pifithrin | [Topotecan co-treated with pifithrin] results in increased degradation of BIRC5 protein | 19812371 |
| C049032 | pinosylvin | [pinosylvin affects the localization of and results in decreased activity of CTNNB1 protein] which results in decreased expression of BIRC5 mRNA | 23333577 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of BIRC5 mRNA | 18301758|2381119 |
| D010894 | Piroxicam | Cisplatin inhibits the reaction [Piroxicam results in increased expression of BIRC5 mRNA] | 21858171 |
| D010894 | Piroxicam | Piroxicam results in increased expression of BIRC5 mRNA | 21858171 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein] | 23452621 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [TNFSF10 protein results in decreased expression of BIRC5 protein] | 20971099 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of BIRC5 mRNA | 23557933 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of BIRC5 protein | 24021570|2544919 |
| D010936 | Plant Extracts | Plant Extracts inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in increased expression of BIRC5 protein] | 25449198 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of BIRC5 mRNA | 20653974 |
| D010936 | Plant Extracts | Plant Extracts results in decreased expression of BIRC5 protein | 20653974 |
| C013649 | plastochromanol 8 | plastochromanol 8 results in decreased expression of BIRC5 mRNA | 23941772 |
| C108953 | platycodin D | Everolimus promotes the reaction [platycodin D results in decreased expression of BIRC5 protein] | 28711525 |
| C108953 | platycodin D | platycodin D promotes the reaction [Everolimus results in decreased expression of BIRC5 protein] | 28711525 |
| C108953 | platycodin D | platycodin D results in decreased expression of BIRC5 protein | 28711525 |
| D011078 | Polychlorinated Biphenyls | Polychlorinated Biphenyls analog results in increased expression of BIRC5 mRNA | 16474171 |
| D011070 | Poly I-C | Poly I-C promotes the reaction [arsenic trioxide results in decreased expression of BIRC5 protein] | 21418039 |
| D059808 | Polyphenols | Polyphenols results in decreased expression of BIRC5 protein | 24021570 |
| C556217 | polyphyllin I | polyphyllin I results in decreased expression of BIRC5 protein | 26821882 |
| C023617 | pregna-4,17-diene-3,16-dione | "pregna-4,17-diene-3,16-dione inhibits the reaction [TNF protein results in increased expression of BIRC5 mRNA]" | 15322087 |
| D011285 | Pregnenolone Carbonitrile | Pregnenolone Carbonitrile results in increased expression of BIRC5 mRNA | 22698814|2890350 |
| D011335 | Proadifen | Proadifen inhibits the reaction [Cisplatin results in increased expression of BIRC5 protein] | 26721606 |
| D011353 | Prodigiosin | BIRC5 results in decreased susceptibility to Prodigiosin | 19133282 |
| D011353 | Prodigiosin | Prodigiosin inhibits the reaction [Paclitaxel results in increased expression of BIRC5 protein] | 19133282 |
| D011353 | Prodigiosin | Prodigiosin results in decreased expression of BIRC5 mRNA | 19133282 |
| D011353 | Prodigiosin | Prodigiosin results in decreased expression of BIRC5 protein | 19133282 |
| D011374 | Progesterone | Progesterone results in decreased expression of BIRC5 mRNA | 23012394|2301818 |
| D011374 | Progesterone | Progesterone results in decreased expression of BIRC5 mRNA | 21795739 |
| D011374 | Progesterone | Progesterone results in increased expression of BIRC5 mRNA | 21549006 |
| C045950 | propiconazole | propiconazole results in increased expression of BIRC5 mRNA | 21278054|2594923 |
| C005556 | propionaldehyde | propionaldehyde results in decreased expression of BIRC5 mRNA | 26079696 |
| D011429 | Propolis | [Butylhydroxybutylnitrosamine co-treated with Propolis analog] results in increased expression of BIRC5 mRNA | 26111810 |
| D011441 | Propylthiouracil | Propylthiouracil results in increased expression of BIRC5 mRNA | 24780913 |
| D011441 | Propylthiouracil | Propylthiouracil results in decreased expression of BIRC5 mRNA | 17403546 |
| C033607 | puerarin | arsenic trioxide promotes the reaction [puerarin results in decreased expression of BIRC5 mRNA] | 20416161 |
| C033607 | puerarin | puerarin results in decreased expression of BIRC5 mRNA | 20416161 |
| D011692 | Puromycin Aminonucleoside | Puromycin Aminonucleoside results in increased expression of BIRC5 mRNA | 19617259 |
| D011692 | Puromycin Aminonucleoside | Puromycin Aminonucleoside results in increased expression of BIRC5 protein | 19617259 |
| C572726 | pycnidione | pycnidione results in decreased expression of BIRC5 protein | 22450442 |
| C513428 | pyrachlostrobin | pyrachlostrobin results in increased expression of BIRC5 mRNA | 27029645 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [arsenic trioxide results in decreased expression of BIRC5 protein] | 16328441|2159458 |
| C432165 | pyrazolanthrone | "pyrazolanthrone inhibits the reaction [naphtho(1,2-b)furan-4,5-dione results in decreased expression of BIRC5 protein]" | 19747539 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [sodium arsenite results in decreased expression of BIRC5 mRNA] | 22706169 |
| C432165 | pyrazolanthrone | pyrazolanthrone inhibits the reaction [sodium arsenite results in decreased expression of BIRC5 protein] | 22706169 |
| C014175 | pyrazolo(3,4-d)pyrimidine | "pyrazolo(3,4-d)pyrimidine analog affects the expression of BIRC5 mRNA" | 21152443 |
| C014175 | pyrazolo(3,4-d)pyrimidine | "pyrazolo(3,4-d)pyrimidine analog affects the expression of BIRC5 mRNA" | 21152443 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [resveratrol results in increased expression of BIRC5 mRNA] | 21161674 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Testosterone results in increased expression of BIRC5 mRNA] | 16139439 |
| C020972 | pyrrolidine dithiocarbamic acid | pyrrolidine dithiocarbamic acid inhibits the reaction [Testosterone results in increased expression of BIRC5 protein] | 16139439 |
| D011794 | Quercetin | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [Quercetin results in decreased expression of BIRC5 protein] | 18377872 |
| D011794 | Quercetin | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Quercetin results in decreased expression of BIRC5 protein] | 17548900 |
| D011794 | Quercetin | [Cisplatin co-treated with Quercetin] results in decreased expression of BIRC5 protein | 16082193 |
| D011794 | Quercetin | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [Quercetin results in decreased expression of BIRC5 protein] | 18377872 |
| D011794 | Quercetin | [Quercetin analog co-treated with Nickel] results in decreased expression of BIRC5 protein | 20577783 |
| D011794 | Quercetin | [Quercetin co-treated with hyperoside] results in decreased expression of BIRC5 mRNA | 24173369 |
| D011794 | Quercetin | [Quercetin co-treated with hyperoside] results in decreased expression of BIRC5 protein | 24173369 |
| D011794 | Quercetin | Quercetin inhibits the reaction [SP1 protein binds to BIRC5 promoter] | 18377872 |
| D011794 | Quercetin | Quercetin inhibits the reaction [TNFSF10 protein results in increased expression of BIRC5 protein] | 21933852 |
| D011794 | Quercetin | Quercetin results in decreased expression of BIRC5 mRNA | 19440933|2193385 |
| D011794 | Quercetin | Quercetin results in decreased expression of BIRC5 protein | 16082193|1754890 |
| D011794 | Quercetin | Quercetin results in increased expression of BIRC5 protein | 14988404 |
| D011794 | Quercetin | [resveratrol co-treated with Quercetin] results in decreased expression of BIRC5 mRNA | 23530649 |
| D011794 | Quercetin | [resveratrol co-treated with Quercetin] results in decreased expression of BIRC5 protein | 23530649 |
| D011794 | Quercetin | "Quercetin inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BIRC5 mRNA]" | 22044346 |
| D011794 | Quercetin | Quercetin inhibits the reaction [Monocrotaline results in increased expression of BIRC5 mRNA] | 25460361 |
| C523166 | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside | quercetin 3-O-beta-(2''-galloyl)-rhamnopyranoside inhibits the reaction [TNFSF10 protein results in decreased expression of BIRC5 protein] | 23711929 |
| D017382 | Reactive Oxygen Species | [Sulindac results in increased abundance of Reactive Oxygen Species] which results in decreased expression of BIRC5 protein | 17136320 |
| C052785 | rebamipide | rebamipide results in decreased expression of BIRC5 mRNA | 15993841 |
| C052785 | rebamipide | rebamipide results in decreased expression of BIRC5 protein | 15993841 |
| D012110 | Reserpine | Reserpine binds to BIRC5 promoter | 17968851 |
| D012116 | Resins, Plant | "Resins, Plant results in decreased expression of BIRC5 protein" | 27268964 |
| C059514 | resveratrol | "[2,5,7,8-tetramethyl-2R-(4R,8R,12-trimethyltridecyl)chroman-6-yloxy acetic acid co-treated with methylselenic acid co-treated with resveratrol] results in decreased expression of BIRC5 protein" | 18444175 |
| C059514 | resveratrol | [Coumestrol co-treated with resveratrol] results in increased expression of BIRC5 mRNA | 19167446 |
| C059514 | resveratrol | Erlotinib Hydrochloride promotes the reaction [resveratrol results in decreased expression of BIRC5 protein] | 25895606 |
| C059514 | resveratrol | pyrrolidine dithiocarbamic acid inhibits the reaction [resveratrol results in increased expression of BIRC5 mRNA] | 21161674 |
| C059514 | resveratrol | [resveratrol co-treated with Quercetin] results in decreased expression of BIRC5 mRNA | 23530649 |
| C059514 | resveratrol | [resveratrol co-treated with Quercetin] results in decreased expression of BIRC5 protein | 23530649 |
| C059514 | resveratrol | [resveratrol co-treated with sorafenib] results in decreased expression of BIRC5 protein | 26911335 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 protein] | 23452621 |
| C059514 | resveratrol | resveratrol promotes the reaction [Erlotinib Hydrochloride results in decreased expression of BIRC5 protein] | 25895606 |
| C059514 | resveratrol | resveratrol results in decreased expression of BIRC5 mRNA | 17261084|1727014 |
| C059514 | resveratrol | resveratrol results in decreased expression of BIRC5 protein | 15763656|1700701 |
| C059514 | resveratrol | resveratrol results in increased expression of BIRC5 mRNA | 21161674 |
| C059514 | resveratrol | BIRC5 protein affects the reaction [resveratrol results in increased cleavage of CASP3 protein] | 22137261 |
| C059514 | resveratrol | BIRC5 protein affects the reaction [resveratrol results in increased cleavage of CASP9 protein] | 22137261 |
| C059514 | resveratrol | "resveratrol inhibits the reaction [9,10-Dimethyl-1,2-benzanthracene results in increased expression of BIRC5 protein]" | 18791811 |
| C059514 | resveratrol | resveratrol results in decreased expression of and results in decreased phosphorylation of BIRC5 protein | 15837718 |
| C059514 | resveratrol | resveratrol results in decreased expression of BIRC5 mRNA | 15837718 |
| C059514 | resveratrol | resveratrol results in decreased expression of BIRC5 protein | 22137261|2550515 |
| C059514 | resveratrol | resveratrol results in increased expression of BIRC5 mRNA | 16081268 |
| C059514 | resveratrol | SIRT1 protein affects the reaction [resveratrol results in decreased expression of BIRC5 protein] | 22137261 |
| C059514 | resveratrol | wortmannin promotes the reaction [resveratrol results in decreased expression of BIRC5 protein] | 22137261 |
| C059514 | resveratrol | resveratrol results in decreased expression of BIRC5 mRNA | 24092990 |
| C059514 | resveratrol | resveratrol results in increased expression of BIRC5 mRNA | 23419489 |
| D015474 | Isotretinoin | Isotretinoin results in decreased expression of BIRC5 protein | 16135400 |
| D012176 | Retinoids | Retinoids results in decreased expression of BIRC5 protein | 19067706 |
| D019438 | Ritonavir | Ritonavir results in decreased expression of BIRC5 mRNA | 16174765|2127066 |
| D019438 | Ritonavir | Ritonavir results in decreased expression of BIRC5 protein | 21270666 |
| C087123 | romidepsin | [romidepsin co-treated with Bortezomib] results in increased cleavage of BIRC5 protein | 18223231 |
| C104586 | roscovitine | roscovitine results in decreased expression of BIRC5 protein | 16230394 |
| C089730 | rosiglitazone | rosiglitazone results in decreased expression of BIRC5 mRNA | 19467017|1973182 |
| C089730 | rosiglitazone | Tretinoin promotes the reaction [rosiglitazone results in decreased expression of BIRC5 mRNA] | 19467017|1973182 |
| C064116 | S-(1,1,2,2-tetrafluoroethyl)cysteine | "S-(1,1,2,2-tetrafluoroethyl)cysteine results in decreased expression of BIRC5 mRNA" | 16678137 |
| C093642 | SB 203580 | SB 203580 affects the reaction [[gambogic acid co-treated with Doxorubicin] affects the expression of BIRC5 protein] | 25824409 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [arsenic trioxide results in decreased expression of BIRC5 protein] | 16328441|2159458 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [baicalein results in decreased expression of BIRC5 protein] | 18025287 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [tanshinone results in decreased expression of BIRC5 mRNA] | 21165580 |
| C093642 | SB 203580 | SB 203580 results in increased expression of BIRC5 mRNA | 21165580 |
| C417521 | SB 216763 | SB 216763 results in increased expression of BIRC5 mRNA | 16288908 |
| C115461 | SC 560 | SC 560 results in decreased expression of BIRC5 mRNA | 17270149 |
| C115461 | SC 560 | SC 560 results in decreased expression of BIRC5 protein | 16391822|1727014 |
| D012643 | Selenium | BIRC5 protein affects the susceptibility to Selenium | 17876054 |
| D012643 | Selenium | [Selenium analog co-treated with Magnesium Oxide analog] inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA] | 27920530 |
| D012643 | Selenium | Selenium analog inhibits the reaction [Diazinon results in decreased expression of BIRC5 mRNA] | 27920530 |
| C078903 | seocalcitol | seocalcitol results in decreased expression of BIRC5 protein | 18567002 |
| D012822 | Silicon Dioxide | Silicon Dioxide results in increased expression of BIRC5 mRNA | 26345256 |
| D012834 | Silver | Silver results in decreased expression of BIRC5 mRNA | 27131904 |
| C440975 | silybin | [silybin co-treated with arsenic trioxide] results in decreased expression of BIRC5 mRNA | 21969006 |
| C440975 | silybin | silybin results in decreased expression of BIRC5 | 24440808 |
| C440975 | silybin | [silybin results in decreased expression of BIRC5] which results in increased susceptibility to TNFSF10 protein | 24440808 |
| D019821 | Simvastatin | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Simvastatin results in decreased expression of BIRC5 protein] | 20464445 |
| D019821 | Simvastatin | Simvastatin inhibits the reaction [TNF protein results in increased expression of BIRC5 protein] | 17277159 |
| D019821 | Simvastatin | Simvastatin promotes the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one results in decreased expression of BIRC5 protein] | 20464445 |
| D019821 | Simvastatin | Simvastatin results in decreased expression of BIRC5 mRNA | 20464445 |
| D019821 | Simvastatin | Simvastatin results in decreased expression of BIRC5 protein | 20464445 |
| D020123 | Sirolimus | [fulvestrant co-treated with Sirolimus] results in decreased expression of BIRC5 mRNA | 19016759 |
| D020123 | Sirolimus | "Sirolimus inhibits the reaction [N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide results in increased expression of and affects the localization of BIRC5 protein]" | 24444656 |
| D020123 | Sirolimus | Sirolimus promotes the reaction [Tamoxifen results in decreased expression of BIRC5 protein] | 19931998 |
| D020123 | Sirolimus | Sirolimus results in decreased expression of BIRC5 protein | 19931998|2160156 |
| C000619853 | SM-1 compound | [SM-1 compound co-treated with Fluorouracil] results in decreased expression of BIRC5 mRNA | 28599477 |
| C000619853 | SM-1 compound | SM-1 compound inhibits the reaction [Fluorouracil results in increased expression of BIRC5 mRNA] | 28599477 |
| C000619853 | SM-1 compound | SM-1 compound promotes the reaction [Fluorouracil results in decreased expression of BIRC5 protein] | 28599477 |
| C000619853 | SM-1 compound | SM-1 compound results in decreased expression of BIRC5 mRNA | 28599477 |
| C110881 | S-nitro-N-acetylpenicillamine | 4-(4-fluorophenyl)-2-(4-hydroxyphenyl)-5-(4-pyridyl)imidazole inhibits the reaction [S-nitro-N-acetylpenicillamine results in decreased expression of BIRC5 protein] | 14988404 |
| C110881 | S-nitro-N-acetylpenicillamine | S-nitro-N-acetylpenicillamine results in decreased expression of BIRC5 mRNA | 14988404 |
| C110881 | S-nitro-N-acetylpenicillamine | S-nitro-N-acetylpenicillamine results in decreased expression of BIRC5 protein | 14988404 |
| C017947 | sodium arsenite | pyrazolanthrone inhibits the reaction [sodium arsenite results in decreased expression of BIRC5 mRNA] | 22706169 |
| C017947 | sodium arsenite | pyrazolanthrone inhibits the reaction [sodium arsenite results in decreased expression of BIRC5 protein] | 22706169 |
| C017947 | sodium arsenite | RELA mutant form inhibits the reaction [sodium arsenite results in increased expression of BIRC5 mRNA] | 22706169 |
| C017947 | sodium arsenite | RELA mutant form inhibits the reaction [sodium arsenite results in increased expression of BIRC5 protein] | 22706169 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of BIRC5 mRNA | 16497974|2270616 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of BIRC5 protein | 16497974|2270616 |
| C017947 | sodium arsenite | [sodium arsenite results in decreased expression of BIRC5] which results in increased activity of CASP3 protein | 16497974 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of BIRC5 mRNA | 22706169|2859598 |
| C017947 | sodium arsenite | sodium arsenite results in increased expression of BIRC5 protein | 14988404|2270616 |
| C017947 | sodium arsenite | TP53 mutant form inhibits the reaction [sodium arsenite results in decreased expression of BIRC5 protein] | 22706169 |
| C017947 | sodium arsenite | U 0126 inhibits the reaction [sodium arsenite results in increased expression of BIRC5 mRNA] | 22706169 |
| C017947 | sodium arsenite | U 0126 inhibits the reaction [sodium arsenite results in increased expression of BIRC5 protein] | 22706169 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of BIRC5 mRNA | 17998272 |
| C017947 | sodium arsenite | sodium arsenite results in decreased expression of BIRC5 protein | 20336670 |
| D012969 | Sodium Fluoride | Sodium Fluoride results in increased expression of BIRC5 mRNA | 27862939 |
| D053260 | Soot | Soot results in increased expression of BIRC5 mRNA | 22461453|2655175 |
| C471405 | sorafenib | [resveratrol co-treated with sorafenib] results in decreased expression of BIRC5 protein | 26911335 |
| C471405 | sorafenib | sorafenib analog results in decreased expression of BIRC5 protein | 21531053 |
| C471405 | sorafenib | sorafenib inhibits the reaction [IGF1 protein results in increased expression of BIRC5 protein] | 21601561 |
| C471405 | sorafenib | sorafenib results in decreased expression of BIRC5 mRNA | 26409325 |
| C471405 | sorafenib | sorafenib results in decreased expression of BIRC5 protein | 18200035|2047332 |
| C471405 | sorafenib | [[[sorafenib results in increased expression of ATF4 protein] which results in increased expression of DDIT4 protein] which results in decreased activity of MTOR protein] which results in decreased expression of BIRC5 protein | 21601561 |
| C471405 | sorafenib | [[sorafenib results in increased expression of DDIT4 protein] which results in decreased activity of MTOR protein] which results in decreased expression of BIRC5 protein | 21601561 |
| C471405 | sorafenib | sorafenib results in decreased expression of BIRC5 protein | 21750559 |
| D013141 | Spiro Compounds | Spiro Compounds analog results in decreased expression of BIRC5 protein | 25320076 |
| C517409 | stattic | stattic inhibits the reaction [glycine-extended gastrin 17 results in increased expression of BIRC5 mRNA] | 19153190 |
| D019311 | Staurosporine | Staurosporine results in decreased expression of BIRC5 protein | 16225760 |
| D013467 | Sulindac | BIRC5 protein inhibits the reaction [Sulindac results in decreased expression of STAT3 protein] | 17401459 |
| D013467 | Sulindac | BIRC5 protein inhibits the reaction [Sulindac results in decreased expression of STAT3 protein modified form] | 17401459 |
| D013467 | Sulindac | [Sulindac co-treated with arsenic trioxide] results in decreased expression of BIRC5 protein | 18281123 |
| D013467 | Sulindac | [Sulindac co-treated with vorinostat] results in decreased expression of BIRC5 mRNA | 18156316 |
| D013467 | Sulindac | [Sulindac co-treated with vorinostat] results in decreased expression of BIRC5 protein | 18156316 |
| D013467 | Sulindac | Sulindac results in decreased expression of BIRC5 mRNA | 11906190|1461021 |
| D013467 | Sulindac | Sulindac results in decreased expression of BIRC5 protein | 14610217|1740145 |
| D013467 | Sulindac | [Sulindac results in increased abundance of Reactive Oxygen Species] which results in decreased expression of BIRC5 protein | 17136320 |
| C473478 | sunitinib | Chloroquine promotes the reaction [sunitinib results in decreased expression of BIRC5 protein] | 24751611 |
| C473478 | sunitinib | sunitinib results in decreased expression of BIRC5 protein | 24751611 |
| D016559 | Tacrolimus | Tacrolimus results in decreased expression of BIRC5 mRNA | 16574167 |
| D013629 | Tamoxifen | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of BIRC5 mRNA | 22046442 |
| D013629 | Tamoxifen | [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one co-treated with Tamoxifen] results in decreased expression of BIRC5 protein | 22046442 |
| D013629 | Tamoxifen | BIRC5 protein results in decreased susceptibility to Tamoxifen | 18815881 |
| D013629 | Tamoxifen | BIRC5 results in decreased susceptibility to Tamoxifen | 18815881 |
| D013629 | Tamoxifen | Sirolimus promotes the reaction [Tamoxifen results in decreased expression of BIRC5 protein] | 19931998 |
| D013629 | Tamoxifen | Tamoxifen results in decreased expression of BIRC5 mRNA | 19931998 |
| D013629 | Tamoxifen | Tamoxifen results in decreased expression of BIRC5 protein | 19931998 |
| D013629 | Tamoxifen | Tamoxifen affects the expression of BIRC5 mRNA | 17555576 |
| C021751 | tanshinone | SB 203580 inhibits the reaction [tanshinone results in decreased expression of BIRC5 mRNA] | 21165580 |
| C021751 | tanshinone | tanshinone inhibits the reaction [Cisplatin results in increased expression of BIRC5 mRNA] | 21165580 |
| C021751 | tanshinone | tanshinone results in decreased expression of BIRC5 mRNA | 21165580 |
| C047246 | temozolomide | temozolomide results in decreased expression of BIRC5 protein | 28122345 |
| C047246 | temozolomide | XAF1 protein promotes the reaction [temozolomide results in decreased expression of BIRC5 protein] | 28122345 |
| C076852 | terameprocol | terameprocol results in decreased expression of BIRC5 mRNA | 15958646 |
| C076852 | terameprocol | terameprocol results in decreased expression of BIRC5 protein | 15958646 |
| D013739 | Testosterone | Calcitriol promotes the reaction [Testosterone results in increased expression of BIRC5 mRNA] | 21592394 |
| D013739 | Testosterone | gingerol inhibits the reaction [Testosterone results in increased expression of BIRC5 protein] | 18030663 |
| D013739 | Testosterone | pyrrolidine dithiocarbamic acid inhibits the reaction [Testosterone results in increased expression of BIRC5 mRNA] | 16139439 |
| D013739 | Testosterone | pyrrolidine dithiocarbamic acid inhibits the reaction [Testosterone results in increased expression of BIRC5 protein] | 16139439 |
| D013739 | Testosterone | [Testosterone co-treated with Calcitriol] results in decreased expression of BIRC5 mRNA | 21592394 |
| D013739 | Testosterone | Testosterone promotes the reaction [Calcitriol results in increased expression of BIRC5 mRNA] | 21592394 |
| D013739 | Testosterone | Testosterone results in decreased expression of BIRC5 mRNA | 21592394 |
| D013739 | Testosterone | Testosterone results in increased expression of BIRC5 protein | 18030663 |
| D013739 | Testosterone | gingerol inhibits the reaction [Testosterone results in increased expression of BIRC5 protein] | 18030663 |
| D013739 | Testosterone | Testosterone results in increased expression of BIRC5 protein | 18030663 |
| C020806 | tetrabromobisphenol A | tetrabromobisphenol A affects the expression of BIRC5 mRNA | 26988606 |
| D013749 | Tetrachlorodibenzodioxin | AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of BIRC5 mRNA] | 15034205 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin affects the expression of BIRC5 mRNA | 21570461 |
| D013749 | Tetrachlorodibenzodioxin | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of BIRC5 mRNA | 17942748 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in decreased expression of BIRC5 mRNA | 15034205 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of BIRC5 mRNA | 19520675|2584352 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of BIRC5 protein | 25843524 |
| D013750 | Tetrachloroethylene | Tetrachloroethylene results in increased expression of BIRC5 mRNA | 19031421 |
| C117155 | tetracycline CMT-3 | tetracycline CMT-3 results in decreased expression of BIRC5 protein | 15688368 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of BIRC5 mRNA | 19031421 |
| C009438 | tetrandrine | tetrandrine binds to BIRC5 promoter | 17968851 |
| C009438 | tetrandrine | tetrandrine results in decreased expression of BIRC5 mRNA | 18495333 |
| D019284 | Thapsigargin | Thapsigargin results in increased expression of BIRC5 protein | 12609713 |
| D019284 | Thapsigargin | Ursodeoxycholic Acid inhibits the reaction [Thapsigargin results in increased expression of BIRC5 protein] | 12609713 |
| D013849 | Thimerosal | BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP3 protein] | 23145070 |
| D013849 | Thimerosal | BIRC5 mutant form promotes the reaction [Thimerosal results in increased cleavage of CASP9 protein] | 23145070 |
| D013849 | Thimerosal | BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP3 protein] | 23145070 |
| D013849 | Thimerosal | BIRC5 protein inhibits the reaction [Thimerosal results in increased cleavage of CASP9 protein] | 23145070 |
| D013849 | Thimerosal | IGF1 protein inhibits the reaction [Thimerosal results in decreased expression of BIRC5 protein] | 23145070 |
| D013849 | Thimerosal | Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP3 protein] | 23145070 |
| D013849 | Thimerosal | Thimerosal promotes the reaction [BIRC5 mutant form results in increased cleavage of CASP9 protein] | 23145070 |
| D013849 | Thimerosal | Thimerosal results in decreased expression of BIRC5 protein | 23145070 |
| D013853 | Thioacetamide | Thioacetamide results in increased expression of BIRC5 mRNA | 23411599 |
| C009495 | titanium dioxide | [Vitallium analog binds to titanium dioxide] which results in decreased expression of BIRC5 mRNA | 23825117 |
| C009495 | titanium dioxide | titanium dioxide results in increased expression of BIRC5 mRNA | 23557971 |
| D014028 | Tobacco Smoke Pollution | NFE2L2 protein promotes the reaction [Tobacco Smoke Pollution affects the expression of BIRC5 mRNA] | 20133372 |
| D014028 | Tobacco Smoke Pollution | Tobacco Smoke Pollution affects the expression of BIRC5 mRNA | 20133372 |
| D024505 | Tocopherols | Tocopherols results in increased expression of BIRC5 mRNA | 17056531 |
| D019772 | Topotecan | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [[pifithrin co-treated with Topotecan] results in increased degradation of BIRC5 protein] | 19812371 |
| D019772 | Topotecan | [Topotecan co-treated with pifithrin] results in increased degradation of BIRC5 protein | 19812371 |
| D019772 | Topotecan | benzyloxycarbonylleucyl-leucyl-leucine aldehyde inhibits the reaction [Topotecan results in increased degradation of BIRC5 protein] | 19812371 |
| D019772 | Topotecan | Topotecan results in increased degradation of BIRC5 protein | 19812371 |
| D019772 | Topotecan | TRP53 inhibits the reaction [Topotecan results in increased degradation of BIRC5 protein] | 19812371 |
| D019772 | Topotecan | [oxaliplatin co-treated with Topotecan] results in decreased expression of BIRC5 mRNA | 25729387 |
| D019772 | Topotecan | Topotecan results in decreased expression of BIRC5 mRNA | 25729387 |
| C496197 | trans-10,cis-12-conjugated linoleic acid | "trans-10,cis-12-conjugated linoleic acid results in decreased expression of BIRC5 mRNA" | 17951470 |
| D014212 | Tretinoin | FLT3 gene mutant form promotes the reaction [[D-65476 co-treated with Tretinoin] results in decreased expression of BIRC5 mRNA] | 16473406 |
| D014212 | Tretinoin | FLT3 gene mutant form promotes the reaction [[D-65476 co-treated with Tretinoin] results in decreased expression of BIRC5 protein] | 16473406 |
| D014212 | Tretinoin | [Tretinoin co-treated with Paclitaxel] results in decreased expression of BIRC5 protein | 17701358|1809827 |
| D014212 | Tretinoin | [Tretinoin co-treated with zoledronic acid] results in decreased expression of BIRC5 mRNA | 20349282 |
| D014212 | Tretinoin | [Tretinoin co-treated with zoledronic acid] results in decreased expression of BIRC5 protein | 20349282 |
| D014212 | Tretinoin | Tretinoin promotes the reaction [rosiglitazone results in decreased expression of BIRC5 mRNA] | 19467017|1973182 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of BIRC5 mRNA | 16574167|2193413 |
| D014212 | Tretinoin | Tretinoin results in decreased expression of BIRC5 protein | 16135400|1770135 |
| D014212 | Tretinoin | Tretinoin results in increased expression of BIRC5 mRNA | 17198874 |
| C032910 | triadimefon | NR1H3 gene mutant form inhibits the reaction [triadimefon results in increased expression of BIRC5 mRNA] | 25949234 |
| C032910 | triadimefon | triadimefon results in increased expression of BIRC5 mRNA | 25949234 |
| D014241 | Trichloroethylene | Trichloroethylene results in increased expression of BIRC5 mRNA | 25549359 |
| C012589 | trichostatin A | decitabine inhibits the reaction [trichostatin A results in decreased expression of BIRC5 mRNA] | 18718068 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of BIRC5 mRNA | 18718068|1960601 |
| C012589 | trichostatin A | trichostatin A results in decreased expression of BIRC5 protein | 23770000 |
| C015559 | trimellitic anhydride | trimellitic anhydride results in increased expression of BIRC5 mRNA | 19042947 |
| C068051 | tripchlorolide | tripchlorolide affects the reaction [TP53 protein affects the expression of BIRC5 mRNA] | 15916722 |
| C050414 | tripterine | tripterine results in decreased expression of BIRC5 mRNA | 17010675 |
| C016805 | tris(1,3-dichloro-2-propyl)phosphate | "tris(1,3-dichloro-2-propyl)phosphate results in decreased expression of BIRC5 mRNA" | 26179874 |
| C057693 | troglitazone | troglitazone affects the localization of BIRC5 protein | 18407589 |
| C057693 | troglitazone | troglitazone results in decreased expression of BIRC5 mRNA | 16820965|1714393 |
| C057693 | troglitazone | troglitazone results in decreased expression of BIRC5 protein | 16820965|1714393 |
| C447031 | tyrphostin AG 1024 | tyrphostin AG 1024 inhibits the reaction [gefitinib results in increased expression of BIRC5 protein] | 17473213 |
| C101044 | tyrphostin AG 1478 | [tyrphostin AG 1478 results in decreased activity of EGFR protein] which results in decreased expression of BIRC5 protein | 21268125 |
| C113580 | U 0126 | U 0126 inhibits the reaction [arsenic trioxide results in decreased expression of BIRC5 protein] | 21594580 |
| C113580 | U 0126 | U 0126 inhibits the reaction [sodium arsenite results in increased expression of BIRC5 mRNA] | 22706169 |
| C113580 | U 0126 | U 0126 inhibits the reaction [sodium arsenite results in increased expression of BIRC5 protein] | 22706169 |
| C000592878 | UMI-77 | UMI-77 results in decreased expression of BIRC5 protein | 24019208 |
| D014580 | Ursodeoxycholic Acid | Ursodeoxycholic Acid inhibits the reaction [Thapsigargin results in increased expression of BIRC5 protein] | 12609713 |
| D014635 | Valproic Acid | Valproic Acid inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 mRNA] | 22711276 |
| D014635 | Valproic Acid | Valproic Acid affects the expression of BIRC5 mRNA | 25979313 |
| D014635 | Valproic Acid | Valproic Acid results in decreased expression of BIRC5 protein | 21771726 |
| D014635 | Valproic Acid | Valproic Acid results in increased methylation of BIRC5 gene | 29154799 |
| D001335 | Vehicle Emissions | 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [Vehicle Emissions results in decreased expression of BIRC5 mRNA] | 28655636 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in decreased expression of BIRC5 mRNA | 28655636 |
| D001335 | Vehicle Emissions | Vehicle Emissions results in increased methylation of BIRC5 gene | 25560391 |
| C551177 | vemurafenib | [(+)-JQ1 compound co-treated with vemurafenib] results in decreased expression of BIRC5 mRNA | 27169980 |
| C017963 | vinyl carbamate | vinyl carbamate results in increased expression of BIRC5 mRNA | 17163412|1784945 |
| C029297 | vinylidene chloride | vinylidene chloride results in increased expression of BIRC5 mRNA | 26682919 |
| D014800 | Vitallium | [Vitallium analog binds to titanium dioxide] which results in decreased expression of BIRC5 mRNA | 23825117 |
| D014800 | Vitallium | Vitallium analog results in decreased expression of BIRC5 mRNA | 23825117 |
| D012256 | Riboflavin | Riboflavin affects the expression of BIRC5 | 20848206 |
| D014810 | Vitamin E | Vitamin E inhibits the reaction [Benzo(a)pyrene results in decreased expression of BIRC5 protein] | 24664296 |
| D024483 | Vitamin K 3 | Vitamin K 3 affects the expression of BIRC5 mRNA | 20044591 |
| C111237 | vorinostat | vorinostat inhibits the reaction [Oxygen deficiency results in increased expression of BIRC5 mRNA] | 22711276 |
| C111237 | vorinostat | [Sulindac co-treated with vorinostat] results in decreased expression of BIRC5 mRNA | 18156316 |
| C111237 | vorinostat | [Sulindac co-treated with vorinostat] results in decreased expression of BIRC5 protein | 18156316 |
| C111237 | vorinostat | TNFSF10 protein promotes the reaction [vorinostat results in decreased expression of BIRC5 protein] | 17410615 |
| C111237 | vorinostat | vorinostat affects the expression of BIRC5 protein | 20846458 |
| C111237 | vorinostat | [vorinostat co-treated with TNFSF10 protein] results in decreased expression of BIRC5 protein | 19643600 |
| C111237 | vorinostat | vorinostat inhibits the reaction [Paclitaxel results in increased expression of BIRC5 protein] | 19875160 |
| C111237 | vorinostat | vorinostat results in decreased expression of BIRC5 protein | 16144943|1741061 |
| C111237 | vorinostat | [VX680 co-treated with vorinostat] results in decreased phosphorylation of BIRC5 protein | 18829489 |
| C484810 | VX680 | [VX680 co-treated with vorinostat] results in decreased phosphorylation of BIRC5 protein | 18829489 |
| C484810 | VX680 | VX680 results in decreased phosphorylation of BIRC5 protein | 18829489 |
| C009687 | wortmannin | wortmannin promotes the reaction [baicalein results in decreased expression of BIRC5 protein] | 18025287 |
| C009687 | wortmannin | wortmannin results in decreased expression of BIRC5 mRNA | 15065019 |
| C009687 | wortmannin | wortmannin results in decreased expression of BIRC5 protein | 15065019 |
| C009687 | wortmannin | wortmannin promotes the reaction [resveratrol results in decreased expression of BIRC5 protein] | 22137261 |
| C009687 | wortmannin | wortmannin results in decreased expression of BIRC5 protein | 23145070 |
| C523798 | YM 155 | "[N-(4-(2-amino-3-chloropyridin-4-yloxy)-3-fluorophenyl)-4-ethoxy-1-(4-fluorophenyl)-2-oxo-1,2-dihydropyridine-3-carboxamide results in increased expression of BIRC5 protein] which affects the susceptibility to YM 155" | 24444656 |
| C523798 | YM 155 | YM 155 results in decreased expression of BIRC5 mRNA | 23918355 |
| C403304 | zerumbone | zerumbone results in decreased expression of BIRC5 mRNA | 16007145 |
| D015032 | Zinc | Zinc deficiency results in increased expression of BIRC5 mRNA | 22171008 |
| D019345 | Zinc Acetate | motexafin gadolinium affects the reaction [Zinc Acetate results in increased expression of BIRC5 mRNA] | 16357179 |
| D019345 | Zinc Acetate | Zinc Acetate results in increased expression of BIRC5 mRNA | 16357179 |
| C088658 | zoledronic acid | [Tretinoin co-treated with zoledronic acid] results in decreased expression of BIRC5 mRNA | 20349282 |
| C088658 | zoledronic acid | [Tretinoin co-treated with zoledronic acid] results in decreased expression of BIRC5 protein | 20349282 |
| C088658 | zoledronic acid | zoledronic acid results in decreased expression of BIRC5 mRNA | 24714768 |
| C088658 | zoledronic acid | zoledronic acid results in decreased expression of BIRC5 protein | 19036117 |